{"id":3058,"date":"2026-03-10T12:17:55","date_gmt":"2026-03-10T03:17:55","guid":{"rendered":"https:\/\/chiken-net.site\/column\/?p=3058"},"modified":"2026-05-03T06:01:12","modified_gmt":"2026-05-02T21:01:12","slug":"future-medicine-new-drugs-2026","status":"publish","type":"post","link":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/","title":{"rendered":"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027"},"content":{"rendered":"\n<p>2026\u5e74\u307e\u3067\u306b\u5b9f\u7528\u5316\u304c\u671f\u5f85\u3055\u308c\u308b\u753b\u671f\u7684\u306a\u65b0\u85ac\u5019\u88dc\u3068\u3001\u305d\u308c\u3089\u304c\u6cbb\u9a13\u3092\u7d4c\u3066\u79c1\u305f\u3061\u306e\u5143\u306b\u5c4a\u304f\u307e\u3067\u306e\u30d7\u30ed\u30bb\u30b9\u3092\u3001\u5206\u304b\u308a\u3084\u3059\u304f\u89e3\u8aac\u3057\u307e\u3059\u3002<\/p>\n\n\n\n<div class=\"trial-summary\" data-filter=\"category_disease\" style=\"background:#f0faf0;border-left:4px solid #43A047;padding:16px 20px;margin:20px 0;border-radius:0 8px 8px 0\"><p style=\"margin:0;color:#333;line-height:1.8\">\u73fe\u5728\u3001\u75be\u60a3\u3092\u304a\u6301\u3061\u306e\u65b9\u5411\u3051\u3067\u306f<strong>4\u4ef6<\/strong>\u306e\u6cbb\u9a13\u30fb\u30e2\u30cb\u30bf\u30fc\u6848\u4ef6\u304c\u52df\u96c6\u4e2d\u3067\u3059\u3002\u75be\u60a3\u304c\u3042\u308b\u65b9\u30fb\u901a\u9662\u306e\u307f\u30fb\u798f\u5ca1\u7b49\u306e\u6848\u4ef6\u304c\u3042\u308a\u307e\u3059\u3002\u5b9f\u65bd\u30a8\u30ea\u30a2\u306f\u798f\u5ca1\u30fb\u95a2\u897f\u30fb\u95a2\u6771\u3067\u3059\u3002<\/p><p style=\"margin:4px 0 0;font-size:0.8em;color:#888\">\u203b2026-05-03\u6642\u70b9\u3002\u6700\u65b0\u72b6\u6cc1\u306f\u8a18\u4e8b\u672b\u5c3e\u306e\u6848\u4ef6\u4e00\u89a7\u3092\u3054\u78ba\u8a8d\u304f\u3060\u3055\u3044\u3002<\/p><\/div>\n\n\n\n<h2 class=\"wp-block-heading\">2026\u5e74\u3001\u533b\u7642\u306e\u5e38\u8b58\u3092\u5909\u3048\u308b\u300c\u753b\u671f\u7684\u306a\u65b0\u85ac\u300d\u3068\u306f\uff1f<\/h2>\n\n\n\n<p>\u533b\u85ac\u54c1\u696d\u754c\u306f\u3001\u5275\u85ac\u30d7\u30ed\u30bb\u30b9\u306e\u30c7\u30b8\u30bf\u30eb\u5316\u3001\u7cbe\u5bc6\u533b\u7642\u306e\u6df1\u5316\u3001\u6295\u4e0e\u5229\u4fbf\u6027\u306e\u5411\u4e0a\u3068\u3044\u3046\u5927\u304d\u306a\u6f6e\u6d41\u306e\u4e2d\u306b\u3042\u308a\u307e\u3059\u30022025\u5e74\u304b\u30892026\u5e74\u306b\u304b\u3051\u3066\u5e02\u5834\u6295\u5165\u304c\u671f\u5f85\u3055\u308c\u308b\u65b0\u85ac\u5019\u88dc\u306f\u3001\u96e3\u75c5\u3084\u6162\u6027\u75be\u60a3\u306b\u5bfe\u3057\u3001\u6839\u672c\u7684\u306a\u30d1\u30e9\u30c0\u30a4\u30e0\u30b7\u30d5\u30c8\u3092\u3082\u305f\u3089\u3059\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n\n\n\n<p>\u3053\u308c\u3089\u306e\u65b0\u85ac\u304c\u79c1\u305f\u3061\u306b\u5c4a\u304f\u306b\u306f\u3001\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u3092\u78ba\u8a8d\u3059\u308b\u300c\u6cbb\u9a13\uff08\u81e8\u5e8a\u8a66\u9a13\uff09\u300d\u304c\u4e0d\u53ef\u6b20\u3067\u3059\u3002\u672c\u8a18\u4e8b\u3067\u306f\u3001\u6ce8\u76ee\u3055\u308c\u308b\u65b0\u85ac\u5019\u88dc\u306e\u4f5c\u7528\u306e\u4ed5\u7d44\u307f\u3001\u6cbb\u9a13\u306e\u9032\u6357\u3001\u533b\u7642\u74b0\u5883\u3078\u306e\u5f71\u97ff\u3092\u5206\u6790\u3057\u307e\u3059\u3002<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">\u80a5\u6e80\u75c7\u30fb\u7cd6\u5c3f\u75c5\u6cbb\u7642\u306e\u6700\u524d\u7dda\uff1aGLP-1\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac\u306e\u9032\u5316\u3068\u6cbb\u9a13<\/h2>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"1396\" src=\"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112395914-1-scaled.jpg\" alt=\"\u898b\u51fa\u30571\u7528: \u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027 - \u30a4\u30e1\u30fc\u30b8\u30a4\u30e9\u30b9\u30c8\" class=\"wp-image-3056\" srcset=\"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112395914-1-scaled.jpg 2560w, https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112395914-1-300x164.jpg 300w, https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112395914-1-1024x559.jpg 1024w, https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112395914-1-768x419.jpg 768w, https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112395914-1-1536x838.jpg 1536w, https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112395914-1-2048x1117.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/figure>\n\n\n\n<p>\u80a5\u6e80\u75c7\u304a\u3088\u30732\u578b\u7cd6\u5c3f\u75c5\u6cbb\u7642\u3067\u306f\u3001GLP-1\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac\u306e\u6210\u529f\u3092\u53d7\u3051\u3001\u6b21\u4e16\u4ee3\u6cbb\u7642\u85ac\u306f\u300c\u9ad8\u3044\u6e1b\u91cf\u52b9\u679c\u300d\u300c\u7d4c\u53e3\u6295\u4e0e\u306b\u3088\u308b\u5229\u4fbf\u6027\u300d\u300c\u8907\u6570\u306e\u30db\u30eb\u30e2\u30f3\u7d4c\u8def\u306e\u540c\u6642\u6a19\u7684\u5316\u300d\u3092\u8ffd\u6c42\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">\u7d4c\u53e3\u5c0f\u5206\u5b50GLP-1\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac\u300c\u30aa\u30eb\u30d5\u30a9\u30eb\u30b0\u30ea\u30d7\u30ed\u30f3\u300d\u306e\u9769\u65b0\u6027<\/h3>\n\n\n\n<p>Eli Lilly\u304c\u958b\u767a\u4e2d\u306e\u30aa\u30eb\u30d5\u30a9\u30eb\u30b0\u30ea\u30d7\u30ed\u30f3\u306f\u3001\u975e\u30da\u30d7\u30c1\u30c9\u6027\u306e\u7d4c\u53e3\u5c0f\u5206\u5b50GLP-1\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac\u3068\u3057\u3066\u6ce8\u76ee\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5f93\u6765\u306e\u7d4c\u53e3\u30bb\u30de\u30b0\u30eb\u30c1\u30c9\uff08\u30ea\u30d9\u30eb\u30b5\u30b9\uff09\u3068\u7570\u306a\u308a\u3001\u98df\u7269\u3084\u6c34\u306e\u6442\u53d6\u5236\u9650\u304c\u306a\u304f\u3001\u4e00\u65e5\u3069\u306e\u6642\u9593\u5e2f\u3067\u3082\u670d\u7528\u53ef\u80fd\u3067\u5229\u4fbf\u6027\u304c\u9ad8\u3044\u306e\u304c\u7279\u5fb4\u3067\u3059\u3002<\/p>\n\n\n\n<p>\u73fe\u5728\u3001\u80a5\u6e80\u75c7\u304a\u3088\u30732\u578b\u7cd6\u5c3f\u75c5\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7b2cIII\u76f8\u8a66\u9a13\u304c\u9032\u3081\u3089\u308c\u3066\u304a\u308a\u3001\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\u306e\u627f\u8a8d\u306f2026\u5e743\u6708\u9803\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u627f\u8a8d\u3055\u308c\u308c\u3070\u3001\u6ce8\u5c04\u88fd\u5264\u306b\u62b5\u6297\u611f\u3092\u6301\u3064\u60a3\u8005\u5c64\u306b\u65b0\u305f\u306a\u6cbb\u7642\u9078\u629e\u80a2\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">\u30c8\u30ea\u30d7\u30eb\u4f5c\u52d5\u85ac\u300c\u30ec\u30bf\u30c8\u30eb\u30c1\u30c9\u300d\u306b\u3088\u308b\u4ee3\u8b1d\u6539\u5584\u306e\u6700\u5927\u5316<\/h3>\n\n\n\n<p>\u540c\u3058\u304fEli Lilly\u304c\u958b\u767a\u3059\u308b\u30ec\u30bf\u30c8\u30eb\u30c1\u30c9\u306f\u3001GLP-1\u3001GIP\u3001\u30b0\u30eb\u30ab\u30b4\u30f3\u306e\u4e09\u3064\u306e\u53d7\u5bb9\u4f53\u306b\u540c\u6642\u306b\u4f5c\u7528\u3059\u308b\u300c\u30c8\u30ea\u30d7\u30eb\u30a2\u30b4\u30cb\u30b9\u30c8\u300d\u3067\u3059\u3002<\/p>\n\n\n\n<p>\u3053\u306e\u85ac\u5264\u306f\u3001\u6442\u53d6\u30ab\u30ed\u30ea\u30fc\u6291\u5236\u3068\u30a8\u30cd\u30eb\u30ae\u30fc\u6d88\u8cbb\u5897\u5927\u3092\u7d44\u307f\u5408\u308f\u305b\u3001\u5f93\u6765\u306e\u4e8c\u91cd\u4f5c\u52d5\u85ac\u3092\u51cc\u99d5\u3059\u308b\u6e1b\u91cf\u52b9\u679c\u304c\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u7b2cII\u76f8\u8a66\u9a13\u3067\u306f48\u9031\u9593\u3067\u5e73\u574724%\u8d85\u306e\u4f53\u91cd\u6e1b\u5c11\u304c\u5831\u544a\u3055\u308c\u3001\u7b2cIII\u76f8\u8a66\u9a13\u3067\u306f80\u9031\u9593\u306730%\u4ee5\u4e0a\u306e\u6e1b\u91cf\u52b9\u679c\u304c\u793a\u5506\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u809d\u8102\u80aa\u6e1b\u5c11\u3084\u5fc3\u8840\u7ba1\u30ea\u30b9\u30af\u6539\u5584\u3082\u793a\u3057\u3066\u304a\u308a\u3001\u5305\u62ec\u7684\u306a\u4ee3\u8b1d\u6539\u5584\u85ac\u3068\u3057\u3066\u306e\u671f\u5f85\u3082\u9ad8\u307e\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">\u6295\u4e0e\u983b\u5ea6\u306e\u4f4e\u6e1b\u3068\u5229\u4fbf\u6027\u306e\u5411\u4e0a\u3092\u76ee\u6307\u3059\u65b0\u85ac\u5019\u88dc<\/h3>\n\n\n\n<p>\u30a4\u30f3\u30b9\u30ea\u30f3\u6cbb\u7642\u3067\u306f\u3001Novo Nordisk\u958b\u767a\u306e\u30a2\u30a6\u30a3\u30af\u30ea\u304c\u3001\u9031\u4e00\u56de\u6295\u4e0e\u306e\u8d85\u9577\u6301\u7d9a\u578b\u30a4\u30f3\u30b9\u30ea\u30f3\u3068\u3057\u3066\u6ce8\u76ee\u3055\u308c\u307e\u3059\u3002\u5f93\u6765\u306e\u6bce\u65e5\u6295\u4e0e\u304b\u3089\u5287\u7684\u306b\u7c21\u7565\u5316\u3055\u308c\u30012026\u5e743\u670829\u65e5\u306e\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\u627f\u8a8d\u4e88\u5b9a\u306b\u3088\u308a\u670d\u85ac\u9075\u5b88\u306e\u5411\u4e0a\u304c\u671f\u5f85\u3055\u308c\u307e\u3059\u3002<\/p>\n\n\n\n<p>\u30ab\u30b0\u30ea\u30bb\u30de\u306f\u3001\u30bb\u30de\u30b0\u30eb\u30c1\u30c9\u3068\u30a2\u30df\u30ea\u30f3\u30a2\u30ca\u30ed\u30b0\u306e\u30ab\u30b0\u30ea\u30ea\u30f3\u30c1\u30c9\u914d\u5408\u5264\u3067\u3001\u5f37\u529b\u306a\u8840\u7cd6\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u3068\u6e1b\u91cf\u3092\u72d9\u3044\u307e\u3059\u30022026\u5e74\u306b\u306f\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9\u3068\u306e\u76f4\u63a5\u6bd4\u8f03\u8a66\u9a13\u7d50\u679c\u304c\u671f\u5f85\u3055\u308c\u3001\u80a5\u6e80\u75c7\u6cbb\u7642\u5e02\u5834\u306e\u7af6\u4e89\u3092\u6fc0\u5316\u3055\u305b\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th>\u85ac\u5264\u540d<\/th><th>\u4f5c\u7528\u6a5f\u5e8f<\/th><th>\u6295\u4e0e\u7d4c\u8def<\/th><th>\u4e3b\u306a\u5bfe\u8c61\u75be\u60a3<\/th><th>\u30b9\u30c6\u30fc\u30bf\u30b9 \/ \u627f\u8a8d\u4e88\u6e2c<\/th><\/tr><\/thead><tbody><tr><td>\u30aa\u30eb\u30d5\u30a9\u30eb\u30b0\u30ea\u30d7\u30ed\u30f3<\/td><td>GLP-1\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac\uff08\u5c0f\u5206\u5b50\uff09<\/td><td>\u7d4c\u53e3\uff08\u4e00\u65e5\u4e00\u56de\uff09<\/td><td>\u80a5\u6e80\u75c7\u30012\u578b\u7cd6\u5c3f\u75c5<\/td><td>2026\u5e743\u6708\u627f\u8a8d\u4e88\u6e2c<\/td><\/tr><tr><td>\u30ec\u30bf\u30c8\u30eb\u30c1\u30c9<\/td><td>GLP-1\/GIP\/\u30b0\u30eb\u30ab\u30b4\u30f3\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac<\/td><td>\u76ae\u4e0b\u6ce8\u5c04\uff08\u9031\u4e00\u56de\uff09<\/td><td>\u80a5\u6e80\u75c7\u30012\u578b\u7cd6\u5c3f\u75c5\u3001MASH<\/td><td>\u7b2cIII\u76f8\u9032\u884c\u4e2d\uff082026-27\u627f\u8a8d\u4e88\u6e2c\uff09<\/td><\/tr><tr><td>\u30a2\u30a6\u30a3\u30af\u30ea<\/td><td>\u9031\u4e00\u56de\u6295\u4e0e\u578b\u30a4\u30f3\u30b9\u30ea\u30f3<\/td><td>\u76ae\u4e0b\u6ce8\u5c04\uff08\u9031\u4e00\u56de\uff09<\/td><td>2\u578b\u7cd6\u5c3f\u75c5<\/td><td>2026\u5e743\u6708\u627f\u8a8d\u4e88\u6e2c<\/td><\/tr><tr><td>\u30ab\u30b0\u30ea\u30bb\u30de<\/td><td>GLP-1\u53d7\u5bb9\u4f53\/\u30a2\u30df\u30ea\u30f3\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac<\/td><td>\u76ae\u4e0b\u6ce8\u5c04\uff08\u9031\u4e00\u56de\uff09<\/td><td>\u80a5\u6e80\u75c7\u30012\u578b\u7cd6\u5c3f\u75c5<\/td><td>\u7b2cIII\u76f8\u9032\u884c\u4e2d<\/td><\/tr><tr><td>\u30a2\u30df\u30af\u30ec\u30c1\u30f3<\/td><td>GLP-1\/\u30a2\u30df\u30ea\u30f3\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac<\/td><td>\u7d4c\u53e3\u30fb\u76ae\u4e0b\u6ce8\u5c04<\/td><td>\u80a5\u6e80\u75c7<\/td><td>\u7b2cII\u76f8\u9032\u884c\u4e2d<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">\u304c\u3093\u6cbb\u7642\u306e\u672a\u6765\u56f3\uff1a\u7cbe\u5bc6\u816b\u760d\u5b66\u3068\u500b\u5225\u5316\u533b\u7642\u3092\u652f\u3048\u308b\u6cbb\u9a13<\/h2>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"1396\" src=\"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112402795-2-scaled.jpg\" alt=\"\u898b\u51fa\u30572\u7528: \u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027 - \u30a4\u30e1\u30fc\u30b8\u30a4\u30e9\u30b9\u30c8\" class=\"wp-image-3057\" srcset=\"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112402795-2-scaled.jpg 2560w, https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112402795-2-300x164.jpg 300w, https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112402795-2-1024x559.jpg 1024w, https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112402795-2-768x419.jpg 768w, https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112402795-2-1536x838.jpg 1536w, https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112402795-2-2048x1117.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/figure>\n\n\n\n<p>\u304c\u3093\u6cbb\u7642\u3067\u306f\u3001\u7279\u5b9a\u306e\u6a19\u7684\u306b\u85ac\u7269\u3092\u5c4a\u3051\u308b\u6280\u8853\u3084\u514d\u75ab\u30b7\u30b9\u30c6\u30e0\u3092\u6d3b\u7528\u3059\u308b\u6226\u7565\u304c\u5b9f\u3092\u7d50\u3093\u3067\u3044\u307e\u3059\u3002ADC\uff08\u6297\u4f53\u85ac\u7269\u8907\u5408\u4f53\uff09\u3068\u4e8c\u7279\u7570\u6027\u6297\u4f53\u306f\u3001\u5f93\u6765\u306e\u5316\u5b66\u7642\u6cd5\u306e\u9650\u754c\u3092\u7a81\u7834\u3059\u308b\u4e3b\u5f79\u3067\u3059\u3002<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">\u6b21\u4e16\u4ee3ADC\u300c\u30c0\u30c8\u30dd\u30bf\u30de\u30d6 \u30c7\u30eb\u30af\u30b9\u30c6\u30ab\u30f3\uff08Dato-DXd\uff09\u300d\u306e\u671f\u5f85<\/h3>\n\n\n\n<p>\u7b2c\u4e00\u4e09\u5171\u3068AstraZeneca\u304c\u5171\u540c\u958b\u767a\u3059\u308b\u30c0\u30c8\u30dd\u30bf\u30de\u30d6 \u30c7\u30eb\u30af\u30b9\u30c6\u30ab\u30f3\u306f\u3001TROP2\u3092\u6a19\u7684\u3068\u3057\u305f\u6b21\u4e16\u4ee3ADC\u3067\u3059\u3002\u72ec\u81ea\u306eDXd\u6280\u8853\u306b\u3088\u308a\u3001\u9ad8\u3044\u85ac\u7269\u6297\u4f53\u6bd4\u3068\u816b\u760d\u7279\u7570\u7684\u306a\u85ac\u7269\u653e\u51fa\u3001\u300c\u30d0\u30a4\u30b9\u30bf\u30f3\u30c0\u30fc\u52b9\u679c\u300d\u3092\u5b9f\u73fe\u3057\u307e\u3059\u3002<\/p>\n\n\n\n<p>\u4e73\u304c\u3093\u306eTROPION-Breast01\u8a66\u9a13\u3067\u306f\u3001\u6a19\u6e96\u5316\u5b66\u7642\u6cd5\u306b\u5bfe\u3057\u7121\u5897\u60aa\u751f\u5b58\u671f\u9593\u3092\u6709\u610f\u306b\u6539\u5584\u3002\u7c73\u56fd\u3067\u306f2025\u5e741\u6708\u306b\u4e73\u304c\u3093\u3067\u627f\u8a8d\u3055\u308c\u3001EGFR\u5909\u7570\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\u3067\u3082\u512a\u5148\u5be9\u67fb\u4e2d\u30672025\u5e74\u7b2c3\u56db\u534a\u671f\u4ee5\u964d\u306e\u627f\u8a8d\u304c\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u65e5\u672c\u3067\u3082\u4e73\u304c\u3093\u3067\u627f\u8a8d\u7533\u8acb\u6e08\u3067\u3059\u3002<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">PD-1\u3068VEGF\u3092\u6a19\u7684\u3068\u3059\u308b\u4e8c\u7279\u7570\u6027\u6297\u4f53\u300c\u30a4\u30dc\u30cd\u30b9\u30b7\u30de\u30d6\u300d\u306e\u53f0\u982d<\/h3>\n\n\n\n<p>\u4e2d\u56fdAkeso\u793e\u958b\u767a\u3001Summit Therapeutics\u5c55\u958b\u306e\u30a4\u30dc\u30cd\u30b9\u30b7\u30de\u30d6\u306f\u3001PD-1\u3068VEGF\u3092\u540c\u6642\u306b\u6a19\u7684\u3068\u3059\u308b\u4e8c\u7279\u7570\u6027\u6297\u4f53\u3067\u3059\u3002\u816b\u760d\u514d\u75ab\u6d3b\u6027\u5316\u3068\u816b\u760d\u8840\u7ba1\u6b63\u5e38\u5316\u3092\u540c\u6642\u306b\u884c\u3044\u3001\u65e2\u5b58\u306e\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u5264\u3092\u8d85\u3048\u308b\u76f8\u4e57\u52b9\u679c\u3092\u72d9\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<p>HARMONi-2\u8a66\u9a13\u3067\u306f\u3001PD-L1\u967d\u6027\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\u306e\u4e00\u6b21\u6cbb\u7642\u306b\u304a\u3044\u3066\u3001\u6a19\u6e96\u6cbb\u7642\u30da\u30e0\u30d6\u30ed\u30ea\u30ba\u30de\u30d6\uff08\u30ad\u30a4\u30c8\u30eb\u30fc\u30c0\uff09\u306b\u5bfe\u3057\u3001\u7121\u5897\u60aa\u751f\u5b58\u671f\u9593\u3092\u6709\u610f\u306b\u6539\u5584\u3057\u307e\u3057\u305f\uff08\u4e2d\u592e\u5024 11.14\u30f6\u6708 \u5bfe 5.82\u30f6\u6708\u3001\u30cf\u30b6\u30fc\u30c9\u6bd4 0.51\uff09 \u3002\u3053\u308c\u306f\u300c\u30ad\u30a4\u30c8\u30eb\u30fc\u30c0\u8d85\u3048\u300d\u3092\u5b9f\u73fe\u3057\u305f\u521d\u306e\u7b2cIII\u76f8\u8a66\u9a13\u3067\u3042\u308a\u30012026\u5e74\u4ee5\u964d\u306e\u514d\u75ab\u7642\u6cd5\u306e\u65b0\u57fa\u6e96\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u9ad8\u3044\u3067\u3059 \u3002<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">\u500b\u5225\u5316mRNA\u304c\u3093\u30ef\u30af\u30c1\u30f3\u300c\u30a4\u30f3\u30c8\u30a3\u30b9\u30e1\u30e9\u30de\u30fb\u30aa\u30fc\u30c8\u30b8\u30fc\u30f3\u300d\u306e\u9032\u6357<\/h3>\n\n\n\n<p>Moderna\u3068Merck\u5171\u540c\u958b\u767a\u306e\u30a4\u30f3\u30c8\u30a3\u30b9\u30e1\u30e9\u30de\u30fb\u30aa\u30fc\u30c8\u30b8\u30fc\u30f3\u306f\u3001\u500b\u3005\u306e\u60a3\u8005\u306e\u816b\u760d\u304b\u3089\u7279\u5b9a\u3055\u308c\u305f\u65b0\u6297\u539f\u3092\u6a19\u7684\u3068\u3059\u308b\u500b\u5225\u5316\u30ef\u30af\u30c1\u30f3\u3067\u3059 \u3002<\/p>\n\n\n\n<p>\u7b2cIIb\u76f8\u8a66\u9a13\uff08KEYNOTE-942\uff09\u306e5\u5e74\u30c7\u30fc\u30bf\u3067\u306f\u3001\u9ad8\u30ea\u30b9\u30af\u30e1\u30e9\u30ce\u30fc\u30de\u306e\u8853\u5f8c\u88dc\u52a9\u7642\u6cd5\u3068\u3057\u3066\u30ad\u30a4\u30c8\u30eb\u30fc\u30c0\u3068\u4f75\u7528\u3059\u308b\u3053\u3068\u3067\u3001\u30ad\u30a4\u30c8\u30eb\u30fc\u30c0\u5358\u5264\u3068\u6bd4\u8f03\u3057\u518d\u767a\u307e\u305f\u306f\u6b7b\u4ea1\u30ea\u30b9\u30af\u309249%\u4f4e\u6e1b \u3002\u7b2cIII\u76f8\u8a66\u9a13\u304c\u9032\u884c\u4e2d\u3067\u30012026\u5e74\u4ee5\u964d\u306e\u30c7\u30fc\u30bf\u304c\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u672c\u6280\u8853\u306f\u30e1\u30e9\u30ce\u30fc\u30de\u4ee5\u5916\u306e\u304c\u3093\u7a2e\u3078\u3082\u5c55\u958b\u3055\u308c\u3066\u304a\u308a\u3001\u304c\u3093\u6cbb\u7642\u306e\u300c\u500b\u5225\u5316\u300d\u3092\u6975\u9650\u307e\u3067\u9ad8\u3081\u308b\u3068\u3057\u3066\u6ce8\u76ee\u3055\u308c\u307e\u3059 \u3002<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th>\u85ac\u5264\u540d<\/th><th>\u30ab\u30c6\u30b4\u30ea<\/th><th>\u6a19\u7684<\/th><th>\u5bfe\u8c61\u75be\u60a3<\/th><th>\u4e3b\u306a\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf<\/th><\/tr><\/thead><tbody><tr><td>\u30c0\u30c8\u30dd\u30bf\u30de\u30d6 \u30c7\u30eb\u30af\u30b9\u30c6\u30ab\u30f3<\/td><td>ADC<\/td><td>TROP2<\/td><td>\u4e73\u304c\u3093\u3001\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093<\/td><td>\u7121\u5897\u60aa\u751f\u5b58\u671f\u9593\u306e\u6709\u610f\u306a\u5ef6\u9577\uff08TROPION-Breast01\/Lung01\uff09 <\/td><\/tr><tr><td>\u30a4\u30dc\u30cd\u30b9\u30b7\u30de\u30d6<\/td><td>\u4e8c\u7279\u7570\u6027\u6297\u4f53<\/td><td>PD-1 \/ VEGF<\/td><td>\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093<\/td><td>\u5bfe\u30ad\u30a4\u30c8\u30eb\u30fc\u30c0\u3067\u7121\u5897\u60aa\u751f\u5b58\u671f\u9593\u30cf\u30b6\u30fc\u30c9\u6bd40.51\uff08HARMONi-2\uff09 <\/td><\/tr><tr><td>\u30e1\u30b8\u30b0\u30c9\u30df\u30c9<\/td><td>\u30bf\u30f3\u30d1\u30af\u8cea\u5206\u89e3\u8a98\u5c0e\u5264<\/td><td>Ikaros \/ Aiolos<\/td><td>\u591a\u767a\u6027\u9aa8\u9ac4\u816b<\/td><td>\u65e2\u5b58\u7642\u6cd5\u8010\u6027\u4f8b\u3078\u306e\u52b9\u679c\uff082026\u5e74\u4ee5\u964d\u627f\u8a8d\u671f\u5f85\uff09 <\/td><\/tr><tr><td>\u30ab\u30df\u30bc\u30b9\u30c8\u30e9\u30f3\u30c8<\/td><td>\u7d4c\u53e3\u9078\u629e\u7684\u30a8\u30b9\u30c8\u30ed\u30b2\u30f3\u53d7\u5bb9\u4f53\u5206\u89e3\u5264<\/td><td>ESR1 \/ ER<\/td><td>\u4e73\u304c\u3093<\/td><td>ESR1\u5909\u7570\u967d\u6027\u4f8b\u3078\u306e\u7279\u7570\u7684\u52b9\u679c <\/td><\/tr><tr><td>\u30a4\u30f3\u30c8\u30a3\u30b9\u30e1\u30e9\u30de\u30fb\u30aa\u30fc\u30c8\u30b8\u30fc\u30f3<\/td><td>\u500b\u5225\u5316\u30ef\u30af\u30c1\u30f3<\/td><td>\u30cd\u30aa\u30a2\u30f3\u30c1\u30b2\u30f3<\/td><td>\u30e1\u30e9\u30ce\u30fc\u30de\u3001\u80ba\u304c\u3093<\/td><td>\u518d\u767a\u30ea\u30b9\u30af49%\u4f4e\u6e1b\uff08KEYNOTE-942 5\u5e74\u30c7\u30fc\u30bf\uff09 <\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">\u795e\u7d4c\u5909\u6027\u75be\u60a3\u3078\u306e\u6311\u6226\uff1a\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u6cbb\u7642\u306e\u6df1\u5316\u3068\u6cbb\u9a13\u306e\u5f79\u5272<\/h2>\n\n\n\n<p>\u30ec\u30ab\u30cd\u30de\u30d6\u3084\u30c9\u30ca\u30cd\u30de\u30d6\u306e\u627f\u8a8d\u306b\u3088\u308a\u3001\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u306f\u300c\u9032\u884c\u3092\u9045\u3089\u305b\u308b\u300d\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u73fe\u5728\u3001\u7814\u7a76\u306f\u52b9\u7387\u7684\u306a\u8133\u5185\u85ac\u5264\u9001\u9054\u6280\u8853\u3068\u3001\u8a8d\u77e5\u6a5f\u80fd\u4f4e\u4e0b\u306b\u76f8\u95a2\u3059\u308b\u300c\u30bf\u30a6\u30bf\u30f3\u30d1\u30af\u8cea\u300d\u306e\u5236\u5fa1\u306b\u7126\u70b9\u3092\u5f53\u3066\u3066\u3044\u307e\u3059 \u3002<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">\u8840\u6db2\u8133\u95a2\u9580\u7a81\u7834\u6280\u8853\u300c\u30c8\u30ed\u30f3\u30c1\u30cd\u30de\u30d6\u300d\u306e\u53ef\u80fd\u6027<\/h3>\n\n\n\n<p>Roche\u304c\u958b\u767a\u3059\u308b\u30c8\u30ed\u30f3\u30c1\u30cd\u30de\u30d6\u306f\u3001\u65e2\u5b58\u306e\u30a2\u30df\u30ed\u30a4\u30c9\u6297\u4f53\u306b\u300c\u8133\u30b7\u30e3\u30c8\u30eb\u300d\u6280\u8853\u3092\u4ed8\u52a0\u3057\u3001\u8840\u6db2\u8133\u95a2\u9580\u3092\u52b9\u7387\u7684\u306b\u901a\u904e\u3055\u305b\u307e\u3059\u3002<\/p>\n\n\n\n<p>\u7b2cIb\u76f8\u8a66\u9a13\u3067\u306f\u3001\u5f93\u6765\u306e\u6297\u4f53\u3088\u308a\u4f4e\u7528\u91cf\u306728\u9031\u9593\u4ee5\u5185\u306b92%\u306e\u60a3\u8005\u304b\u3089\u30a2\u30df\u30ed\u30a4\u30c9\u30d7\u30e9\u30fc\u30af\u304c\u6d88\u5931\u3002ARIA\uff08\u30a2\u30df\u30ed\u30a4\u30c9\u95a2\u9023\u753b\u50cf\u7570\u5e38\uff09\u306e\u767a\u751f\u7387\u3082\u6291\u5236\u3055\u308c\u3001\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u306e\u4e21\u7acb\u304c\u671f\u5f85\u3055\u308c\u307e\u3059\u3002\u73fe\u5728\u3001\u7b2cIII\u76f8\u8a66\u9a13\u304c\u9032\u884c\u4e2d\u3067\u30012028\u5e74\u4ee5\u964d\u306e\u627f\u8a8d\u7533\u8acb\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">\u30bf\u30a6\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u6a19\u7684\u3068\u3059\u308b\u6b21\u4e16\u4ee3\u6cbb\u7642\u306e\u9032\u5c55<\/h3>\n\n\n\n<p>\u30a2\u30df\u30ed\u30a4\u30c9\u9664\u53bb\u306b\u7d9a\u304d\u3001\u30bf\u30a6\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u6a19\u7684\u3068\u3057\u305f\u6cbb\u7642\u304c\u6ce8\u76ee\u3055\u308c\u3066\u3044\u307e\u3059\u3002Biogen\u306eBIIB080\u306f\u3001\u30bf\u30a6\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u7523\u751f\u3092\u6291\u5236\u3059\u308b\u30a2\u30f3\u30c1\u30bb\u30f3\u30b9\u30aa\u30ea\u30b4\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\uff08ASO\uff09\u3067\u3059\u3002\u7b2cIb\u76f8\u8a66\u9a13\u3067\u306f\u3001\u8133\u810a\u9ac4\u6db2\u4e2d\u306e\u30bf\u30a6\u6fc3\u5ea6\u309250-60%\u6e1b\u5c11\u3055\u305b\u3001\u30bf\u30a6\u84c4\u7a4d\u3092\u6291\u5236\u3059\u308b\u3053\u3068\u304c\u78ba\u8a8d\u3055\u308c\u3001\u73fe\u5728\u7b2cII\u76f8\u8a66\u9a13\u304c\u9032\u884c\u4e2d\u3067\u3059\u3002<\/p>\n\n\n\n<p>Arrowhead Pharmaceuticals\u306eARO-MAPT\u306f\u3001RNA\u5e72\u6e09\u3092\u5229\u7528\u3057\u3001\u76ae\u4e0b\u6295\u4e0e\u3067\u8840\u6db2\u8133\u95a2\u9580\u3092\u901a\u904e\u3057\u8133\u5185\u306e\u30bf\u30a6\u7523\u751f\u3092\u6291\u5236\u3057\u307e\u3059\u30022026\u5e74\u304b\u30892027\u5e74\u306b\u304b\u3051\u3066\u3001\u3053\u308c\u3089\u30bf\u30a6\u6a19\u7684\u6cbb\u7642\u306e\u81e8\u5e8a\u7684\u4fa1\u5024\u304c\u660e\u78ba\u306b\u306a\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3001\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u6cbb\u7642\u306e\u65b0\u305f\u306a\u9032\u5c55\u304c\u671f\u5f85\u3055\u308c\u307e\u3059\u3002<\/p>\n\n\n\n<p>\u3053\u308c\u3089\u306e\u65b0\u85ac\u5019\u88dc\u306f\u3001\u6cbb\u9a13\u3092\u901a\u3058\u3066\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u304c\u53b3\u3057\u304f\u691c\u8a3c\u3055\u308c\u3066\u304a\u308a\u3001\u672a\u6765\u306e\u533b\u7642\u3092\u652f\u3048\u308b\u91cd\u8981\u306a\u5f79\u5272\u3092\u62c5\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th>\u85ac\u5264\u540d<\/th><th>\u4f5c\u7528\u6a5f\u5e8f<\/th><th>\u958b\u767a\u30d5\u30a7\u30fc\u30ba<\/th><th>\u7279\u5fb4\u30fb\u671f\u5f85\u3055\u308c\u308b\u52b9\u679c<\/th><\/tr><\/thead><tbody><tr><td>\u30c8\u30ed\u30f3\u30c1\u30cd\u30de\u30d6<\/td><td>\u30a2\u30df\u30ed\u30a4\u30c9\u6297\u4f53 + \u8133\u30b7\u30e3\u30c8\u30eb<\/td><td>\u7b2cIII\u76f8<\/td><td>\u8840\u6db2\u8133\u95a2\u9580\u3092\u52b9\u7387\u7684\u306b\u901a\u904e\u3057\u3001\u4f4e\u7528\u91cf\u3067\u30d7\u30e9\u30fc\u30af\u3092\u5b8c\u5168\u9664\u53bb<\/td><\/tr><tr><td>BIIB080<\/td><td>\u30bf\u30a6\u6a19\u7684\u30a2\u30f3\u30c1\u30bb\u30f3\u30b9\u30aa\u30ea\u30b4\u30cc\u30af\u30ec\u30aa\u30c1\u30c9<\/td><td>\u7b2cII\u76f8<\/td><td>\u30bf\u30a6\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u7523\u751f\u305d\u306e\u3082\u306e\u3092\u6291\u5236<\/td><\/tr><tr><td>ARO-MAPT<\/td><td>\u30bf\u30a6\u6a19\u7684RNA\u5e72\u6e09<\/td><td>\u7b2cI\/IIa\u76f8<\/td><td>\u76ae\u4e0b\u6295\u4e0e\u306b\u3088\u308b\u8133\u5168\u4f53\u3067\u306e\u30bf\u30a6\u30bf\u30f3\u30d1\u30af\u8cea\u9664\u53bb<\/td><\/tr><tr><td>\u30d6\u30e9\u30eb\u30ab\u30e1\u30b7\u30f3<\/td><td>\u30b7\u30b0\u30de-1\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac<\/td><td>\u7b2cII\/III\u76f8<\/td><td>\u7d30\u80de\u5185\u306e\u5ec3\u68c4\u7269\u51e6\u7406\u80fd\u529b\uff08\u30aa\u30fc\u30c8\u30d5\u30a1\u30b8\u30fc\uff09\u306e\u6d3b\u6027\u5316<\/td><\/tr><tr><td>ALZ-801<\/td><td>\u30a2\u30df\u30ed\u30a4\u30c9\u30aa\u30ea\u30b4\u30de\u30fc\u963b\u5bb3\u5264<\/td><td>\u7b2cIII\u76f8<\/td><td>\u7d4c\u53e3\u85ac\u306b\u3088\u308b\u521d\u671f\u30a2\u30df\u30ed\u30a4\u30c9\u51dd\u96c6\u306e\u9632\u6b62<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">\u907a\u4f1d\u5b50\u7de8\u96c6\u3068AI\u5275\u85ac\uff1a\u533b\u7642\u306e\u300c\u5b8c\u6cbb\u300d\u3068\u300c\u958b\u767a\u52a0\u901f\u300d\u3092\u652f\u3048\u308b\u6cbb\u9a13<\/h2>\n\n\n\n<p>\u907a\u4f1d\u5b50\u6cbb\u7642\u306f\u3001\u4f53\u5916\u3067\u306e\u7d30\u80de\u7de8\u96c6\u304b\u3089\u3001\u76f4\u63a5\u4f53\u5185\u306b\u85ac\u5264\u3092\u6295\u4e0e\u3059\u308b\u300cin vivo\u7de8\u96c6\u300d\u3078\u3068\u9032\u5316\u3057\u3066\u3044\u307e\u3059\u3002Intellia Therapeutics\u306f\u3001\u8907\u6570\u306e\u5e0c\u5c11\u75be\u60a3\u3067\u7b2cIII\u76f8\u8a66\u9a13\u3092\u9032\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">\u907a\u4f1d\u6027\u8840\u7ba1\u6027\u6d6e\u816b\u306b\u5bfe\u3059\u308b\u300c\u30ed\u30f3\u30dc\u30b0\u30e9\u30f3\u30fb\u30b8\u30af\u30eb\u30e1\u30e9\u30f3\uff08Lonvo-z\uff09\u300d<\/h3>\n\n\n\n<p>\u30ed\u30f3\u30dc\u30b0\u30e9\u30f3\u30fb\u30b8\u30af\u30eb\u30e1\u30e9\u30f3\u306f\u3001CRISPR\/Cas9\u6280\u8853\u3067\u809d\u81d3\u907a\u4f1d\u5b50\u3092\u4e0d\u6d3b\u5316\u3057\u3001\u30ab\u30ea\u30af\u30ec\u30a4\u30f3\u7523\u751f\u3092\u6291\u3048\u308b\u3053\u3068\u3067\u907a\u4f1d\u6027\u8840\u7ba1\u6027\u6d6e\u816b\u306e\u767a\u4f5c\u3092\u9632\u3050\u6cbb\u7642\u85ac\u3067\u3059\u3002<\/p>\n\n\n\n<p>\u7b2cI\/II\u76f8\u8a66\u9a13\u3067\u306f\u3001\u4e00\u56de\u306e\u6295\u4e0e\u3067\u6700\u95773\u5e74\u9593\u3001\u767a\u4f5c\u304c\u5e73\u574796%\u6e1b\u5c11\u3002\u7b2cIII\u76f8\u8a66\u9a13\u306f\u60a3\u8005\u767b\u9332\u3092\u5b8c\u4e86\u3057\u30012026\u5e74\u534a\u3070\u306e\u30c7\u30fc\u30bf\u767a\u8868\u30012026\u5e74\u5f8c\u534a\u306e\u627f\u8a8d\u7533\u8acb\u30012027\u5e74\u306e\u5e02\u5834\u6295\u5165\u304c\u8a08\u753b\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u627f\u8a8d\u3055\u308c\u308c\u3070\u3001\u4e00\u5ea6\u306e\u6cbb\u7642\u3067\u907a\u4f1d\u6027\u75be\u60a3\u3092\u514b\u670d\u3059\u308b\u8c61\u5fb4\u7684\u306a\u4e8b\u4f8b\u3068\u306a\u308b\u3067\u3057\u3087\u3046\u3002<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">AI\u5275\u85ac\u304c\u533b\u85ac\u54c1\u958b\u767a\u30b5\u30a4\u30af\u30eb\u3092\u5287\u7684\u306b\u77ed\u7e2e<\/h3>\n\n\n\n<p>\u753b\u671f\u7684\u306a\u65b0\u85ac\u5019\u88dc\u306e\u80cc\u666f\u306b\u306f\u3001AI\u306b\u3088\u308b\u5275\u85ac\u30d7\u30ed\u30bb\u30b9\u306e\u52a0\u901f\u304c\u3042\u308a\u307e\u3059\u30022025\u5e74\u304b\u30892026\u5e74\u306b\u304b\u3051\u3001AI\u8a2d\u8a08\u5206\u5b50\u304c\u521d\u306e\u7b2cIII\u76f8\u8a66\u9a13\u7d50\u679c\u3092\u51fa\u3057\u3001\u627f\u8a8d\u3092\u5f97\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<p>AI\u306f\u3001\u5f93\u6765\u306e4-6\u5e74\u304b\u304b\u3063\u3066\u3044\u305f\u30bf\u30fc\u30b2\u30c3\u30c8\u7279\u5b9a\u304b\u3089\u30ea\u30fc\u30c9\u5316\u5408\u7269\u6700\u9069\u5316\u307e\u3067\u306e\u671f\u9593\u3092\u30011\u5e74\u7a0b\u5ea6\u306b\u77ed\u7e2e\u3057\u307e\u3059\u3002Insilico Medicine\u306e\u80ba\u7dda\u7dad\u75c7\u6cbb\u7642\u85acINS018_055\u306f\u3001AI\u3067\u308f\u305a\u304b18\u30f6\u6708\u3067\u30bf\u30fc\u30b2\u30c3\u30c8\u767a\u898b\u304b\u3089\u81e8\u5e8a\u5019\u88dc\u7269\u8cea\u7279\u5b9a\u307e\u3067\u3092\u5b8c\u4e86\u3002\u307e\u305fAI\u306f\u3001\u60a3\u8005\u30c7\u30fc\u30bf\u304b\u3089\u52b9\u679c\u304c\u51fa\u3084\u3059\u3044\u60a3\u8005\u5c64\u3092\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u3057\u3001\u6cbb\u9a13\u6210\u529f\u7387\u3092\u9ad8\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">\u672a\u6765\u306e\u533b\u7642\u3092\u5171\u5275\u3059\u308b\uff1a\u6cbb\u9a13\u53c2\u52a0\u304c\u62d3\u304f\u65b0\u3057\u3044\u5065\u5eb7\u306e\u5f62<\/h2>\n\n\n\n<p>2026\u5e74\u4ee5\u964d\u306e\u533b\u7642\u306f\u3001\u300c\u6cbb\u7642\u304b\u3089\u5b8c\u6cbb\u3078\u300d\u300c\u60a3\u8005\u4e2d\u5fc3\u306e\u5229\u4fbf\u6027\u300d\u300c\u500b\u5225\u5316\u533b\u7642\u306e\u6df1\u5316\u300d\u3078\u3068\u5927\u304d\u304f\u5909\u5bb9\u3057\u307e\u3059\u3002CRISPR\u306b\u3088\u308b\u907a\u4f1d\u7684\u6839\u6cbb\u3084\u500b\u5225\u5316\u304c\u3093\u30ef\u30af\u30c1\u30f3\u306f\u3001\u300c\u5b8c\u6cbb\u300d\u3078\u3068\u533b\u7642\u306e\u8cea\u3092\u8ee2\u63db\u3002\u7d4c\u53e3\u80a5\u6e80\u75c7\u85ac\u3084\u9577\u671f\u4f5c\u7528\u578b\u6cbb\u7642\u85ac\u306f\u3001\u60a3\u8005\u306e\u65e5\u5e38\u751f\u6d3b\u3092\u75c5\u6c17\u306e\u7ba1\u7406\u304b\u3089\u89e3\u653e\u3057\u3001\u670d\u85ac\u9075\u5b88\u3092\u5411\u4e0a\u3055\u305b\u307e\u3059\u3002AI\u306f\u3001\u6700\u9069\u306a\u85ac\u5264\u3092\u6700\u9069\u306a\u30bf\u30a4\u30df\u30f3\u30b0\u3067\u5c4a\u3051\u308b\u57fa\u76e4\u3068\u306a\u308b\u3067\u3057\u3087\u3046\u3002<\/p>\n\n\n\n<p>\u3057\u304b\u3057\u3001\u9769\u65b0\u306b\u306f\u8ab2\u984c\u3082\u6b8b\u308a\u307e\u3059\u3002\u65b0\u85ac\u627f\u8a8d\u6642\u671f\u306e\u56fd\u306b\u3088\u308b\u300c\u30c9\u30e9\u30c3\u30b0\u30fb\u30e9\u30b0\u300d\u3067\u3059\u3002\u65e5\u672c\u3067\u3082\u30aa\u30eb\u30d5\u30a9\u30eb\u30b0\u30ea\u30d7\u30ed\u30f3\u306a\u3069\u306e\u65b0\u85ac\u306f\u30012027\u5e74\u4ee5\u964d\u306e\u767a\u58f2\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u6025\u901f\u306a\u9032\u6b69\u306f\u3001\u533b\u7642\u73fe\u5834\u306e\u77e5\u8b58\u66f4\u65b0\u3084\u3001\u9ad8\u984d\u85ac\u4fa1\u306b\u5bfe\u3059\u308b\u4fdd\u967a\u5236\u5ea6\u306e\u6301\u7d9a\u53ef\u80fd\u6027\u3068\u3044\u3046\u8b70\u8ad6\u3082\u547c\u3073\u307e\u3059\u3002<\/p>\n\n\n\n<p>\u6cbb\u9a13\u3078\u306e\u53c2\u52a0\u306f\u3001\u753b\u671f\u7684\u306a\u65b0\u85ac\u3092\u4e16\u306b\u9001\u308a\u51fa\u3059\u4e0d\u53ef\u6b20\u306a\u8ca2\u732e\u3067\u3059\u3002\u3042\u306a\u305f\u306e\u6642\u9593\u3092\u672a\u6765\u306e\u533b\u7642\u306e\u9032\u6b69\u306b\u6295\u8cc7\u3059\u308b\u3053\u3068\u306f\u3001\u3088\u308a\u5065\u5eb7\u306a\u793e\u4f1a\u3078\u3068\u3064\u306a\u304c\u308b\u9078\u629e\u3068\u306a\u308b\u3067\u3057\u3087\u3046\u3002\u6cbb\u9a13\u306b\u8208\u5473\u304c\u3042\u308c\u3070\u3001\u533b\u85ac\u54c1\u533b\u7642\u6a5f\u5668\u7dcf\u5408\u6a5f\u69cb\u306e\u516c\u5f0f\u30b5\u30a4\u30c8\u3084\u52df\u96c6\u30da\u30fc\u30b8\u3067\u60c5\u5831\u78ba\u8a8d\u3084\u53c2\u52a0\u6761\u4ef6\u306e\u78ba\u8a8d\u304b\u3089\u59cb\u3081\u3066\u307f\u3066\u304f\u3060\u3055\u3044\u30022026\u5e74\u3092\u5883\u306b\u3001\u533b\u85ac\u54c1\u306f\u300c\u5316\u5b66\u7269\u8cea\u300d\u304b\u3089\u300c\u9ad8\u5ea6\u306a\u30c7\u30b8\u30bf\u30eb\u8a2d\u8a08\u306b\u57fa\u3065\u304f\u7cbe\u5bc6\u306a\u6cbb\u7642\u30b7\u30b9\u30c6\u30e0\u300d\u3078\u3068\u9032\u5316\u3057\u307e\u3059\u3002\u672c\u8a18\u4e8b\u306e\u65b0\u85ac\u7fa4\u306f\u3001\u305d\u306e\u9032\u5316\u306e\u6700\u524d\u7dda\u3067\u3042\u308a\u3001\u4eba\u985e\u304c\u514b\u670d\u3067\u304d\u306a\u304b\u3063\u305f\u75c5\u306e\u58c1\u3092\u53d6\u308a\u9664\u3044\u3066\u3044\u304f\u3053\u3068\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n\n\n\n<p>\u65b0\u85ac\u958b\u767a\u306b\u304a\u3051\u308b\u6cbb\u9a13\u306f\u3001\u79d1\u5b66\u7684\u306a\u30a2\u30a4\u30c7\u30a2\u3092\u300c\u4fe1\u983c\u3067\u304d\u308b\u533b\u7642\u300d\u3078\u3068\u6607\u83ef\u3055\u305b\u308b\u3001\u6700\u3082\u91cd\u8981\u3067\u53b3\u683c\u306a\u691c\u8a3c\u30d7\u30ed\u30bb\u30b9\u3067\u3059\u3002<\/p>\n\n\n\n<p>\u7814\u7a76\u5ba4\u3084\u52d5\u7269\u8a66\u9a13\u3067\u826f\u597d\u306a\u7d50\u679c\u304c\u51fa\u3066\u3082\u3001\u30d2\u30c8\u306e\u4f53\u5185\u74b0\u5883\u3067\u540c\u69d8\u306b\u4f5c\u7528\u3059\u308b\u3068\u306f\u9650\u308a\u307e\u305b\u3093\u3002\u6cbb\u9a13\u306f\u3001\u4eba\u306b\u5bfe\u3057<strong>\u300c\u6709\u52b9\u6027\u300d\u3068\u300c\u5b89\u5168\u6027\u300d<\/strong>\u3092\u79d1\u5b66\u7684\u306b\u8a3c\u660e\u3059\u308b\u552f\u4e00\u306e\u624b\u6bb5\u3067\u3059\u3002<\/p>\n\n\n\n<p>\u6cbb\u9a13\u30c7\u30fc\u30bf\u304c\u3001\u539a\u751f\u52b4\u50cd\u7701\u306a\u3069\u306e\u898f\u5236\u5f53\u5c40\u304c\u627f\u8a8d\u3092\u4e0b\u3059\u6700\u5927\u306e\u6839\u62e0\u3068\u306a\u308a\u307e\u3059\u3002\u6cbb\u9a13\u304c\u306a\u3051\u308c\u3070\u3001\u753b\u671f\u7684\u306a\u767a\u898b\u3082\u60a3\u8005\u3055\u3093\u306e\u624b\u5143\u306b\u5c4a\u304f\u3053\u3068\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n\n\n\n<p>\u79d1\u5b66\u7684\u6839\u62e0\u306b\u57fa\u3065\u3044\u305f\u9069\u5207\u306a\u6295\u4e0e\u91cf\u3084\u30ea\u30b9\u30af\u3092\u660e\u78ba\u306b\u3057\u3001\u5c06\u6765\u306e\u60a3\u8005\u3055\u3093\u304c\u5b89\u5fc3\u3057\u3066\u6cbb\u7642\u3092\u53d7\u3051\u3089\u308c\u308b\u571f\u53f0\u3092\u7bc9\u304f\u3053\u3068\u3002\u3053\u308c\u3053\u305d\u304c\u6cbb\u9a13\u306e\u6700\u5927\u306e\u610f\u7fa9\u3067\u3059\u3002<\/p>\n\n\n\n<p><strong>\u6cbb\u9a13\u30cd\u30c3\u30c8\u306b\u3064\u3044\u3066<\/strong><\/p>\n\n\n\n<p>\u300c\u6642\u9593\u3092\u3001\u4fa1\u5024\u306b\u5909\u3048\u308b\u3002\u672a\u6765\u3092\u3001\u5065\u5eb7\u3067\u3064\u306a\u3050\u3002\u300d<\/p>\n\n\n\n<p>\u6cbb\u9a13\u30cd\u30c3\u30c8\u306f\u3001\u6cbb\u9a13\u3078\u306e\u53c2\u52a0\u3092\u300c\u6642\u9593\u306e\u6295\u8cc7\u300d\u3068\u6349\u3048\u3001\u7d0d\u5f97\u3067\u304d\u308b\u60c5\u5831\u63d0\u4f9b\u3092\u5927\u5207\u306b\u3057\u3066\u3044\u307e\u3059\u3002\u30ef\u30af\u30c1\u30f3\u30fb\u751f\u6d3b\u7fd2\u6163\u75c5\u30fb\u7f8e\u5bb9\u306a\u3069\u5e45\u5e83\u3044\u5206\u91ce\u306e\u52df\u96c6\u60c5\u5831\u3092\u63b2\u8f09\u4e2d\u3002\u4f1a\u54e1\u767b\u9332\uff08\u7121\u6599\uff09\u3067\u3001\u3042\u306a\u305f\u306e\u6761\u4ef6\u306b\u5408\u3063\u305f\u6848\u4ef6\u3092\u78ba\u8a8d\u3067\u304d\u307e\u3059\u3002<\/p>\n\n\n\n<p>\u2192 <a href=\"https:\/\/chiken-net.site\/entry\">\u4f1a\u54e1\u767b\u9332\u30da\u30fc\u30b8\u3078<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">\u53c2\u8003\u30fb\u51fa\u5178<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Pipeline Drugs to Watch in Q1 2026 &#8211; CVS Health\uff082026\u5e74\u7b2c1\u56db\u534a\u671f\u306b\u6ce8\u76ee\u3059\u3079\u304d4\u3064\u306e\u533b\u85ac\u54c1\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306b\u3064\u3044\u3066\u89e3\u8aac\u3057\u3066\u304a\u308a\u3001\u6cbb\u7642\u9078\u629e\u80a2\u3092\u518d\u69cb\u7bc9\u3059\u308b\u53ef\u80fd\u6027\u306e\u3042\u308b\u85ac\u5264\u304c\u7d39\u4ecb\u3055\u308c\u3066\u3044\u307e\u3059\u3002\uff09 https:\/\/www.cvshealth.com\/news\/pbm\/four-drugs-to-watch-in-2026-that-could-reshape-treatment-options.html<\/li>\n\n\n\n<li>Blockbuster Contenders: The Class of 2026 &#8211; DCAT Value Chain\uff082026\u5e74\u306b\u5e02\u5834\u6295\u5165\u304c\u671f\u5f85\u3055\u308c\u308b\u5927\u578b\u533b\u85ac\u54c1\u5019\u88dc\u306b\u3064\u3044\u3066\u3001\u305d\u306e\u81e8\u5e8a\u7684\u30fb\u6226\u7565\u7684\u5206\u6790\u304c\u63d0\u4f9b\u3055\u308c\u3066\u3044\u307e\u3059\u3002\uff09 https:\/\/www.dcatvci.org\/features\/blockbuster-contenders-the-class-of-2026\/<\/li>\n\n\n\n<li>Drugs to Watch 2026 &#8211; Top Emerging Therapies &#8211; Clarivate\uff08\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u793e\u304c2026\u5e74\u306b\u6ce8\u76ee\u3059\u3079\u304d\u533b\u85ac\u54c1\u3068\u3057\u3066\u6319\u3052\u305f\u3001\u4e3b\u8981\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u5c06\u6765\u6027\u306b\u95a2\u3059\u308b\u30ec\u30dd\u30fc\u30c8\u3067\u3059\u3002\uff09 https:\/\/clarivate.com\/drugs-to-watch\/<\/li>\n\n\n\n<li>Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report &#8211; PR Newswire\uff08\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u793e\u304c2026\u5e74\u306b\u767a\u8868\u3057\u305f\u300cDrugs to Watch Report\u300d\u3067\u300111\u306e\u6f5c\u5728\u7684\u306a\u5927\u578b\u304a\u3088\u3073\u9769\u65b0\u7684\u6cbb\u7642\u6cd5\u3092\u7279\u5b9a\u3057\u305f\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/www.prnewswire.com\/news-releases\/clarivate-identifies-eleven-potential-blockbuster-and-transformative-therapies-in-its-2026-drugs-to-watch-report-302653631.html<\/li>\n\n\n\n<li>Spotlight On: The drugs that will shape 2026 &#8211; FirstWord Pharma\uff082026\u5e74\u306e\u533b\u85ac\u54c1\u5e02\u5834\u3092\u5f62\u6210\u3059\u308b\u3067\u3042\u308d\u3046\u4e3b\u8981\u306a\u85ac\u5264\u306b\u7126\u70b9\u3092\u5f53\u3066\u305f\u8a18\u4e8b\u3067\u3059\u3002\uff09 https:\/\/firstwordpharma.com\/story\/7084406<\/li>\n\n\n\n<li>11 high-impact drugs to look out for in 2026 &#8211; pharmaphorum\uff082026\u5e74\u306b\u5927\u304d\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u53ef\u80fd\u6027\u306e\u3042\u308b11\u306e\u533b\u85ac\u54c1\u306b\u3064\u3044\u3066\u7d39\u4ecb\u3057\u3066\u3044\u307e\u3059\u3002\uff09 https:\/\/pharmaphorum.com\/news\/11-high-impact-drugs-look-out-2026<\/li>\n\n\n\n<li>Lilly&#8217;s triple G agonist boasts 28.7% weight loss in Phase III trial\uff08\u30a4\u30fc\u30e9\u30a4\u30ea\u30ea\u30fc\u793e\u306e\u30c8\u30ea\u30d7\u30ebG\u30a2\u30b4\u30cb\u30b9\u30c8\u304c\u7b2cIII\u76f8\u8a66\u9a13\u306728.7%\u306e\u4f53\u91cd\u6e1b\u5c11\u3092\u9054\u6210\u3057\u305f\u3068\u3044\u3046\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/www.clinicaltrialsarena.com\/news\/lilly-retatrutide-data-phase-iii-trial\/<\/li>\n\n\n\n<li>Retatrutide FDA Approval Status &amp; Rapid Growth in Demand\uff08\u30ec\u30bf\u30c8\u30eb\u30c1\u30c9\u306e\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\u627f\u8a8d\u72b6\u6cc1\u3068\u9700\u8981\u306e\u6025\u901f\u306a\u4f38\u3073\u306b\u3064\u3044\u3066\u89e3\u8aac\u3057\u3066\u3044\u307e\u3059\u3002\uff09 https:\/\/modernaestheticsmd.com\/med-spa-blog\/retatrutide-fda-approval-status-rapid-growth-in-demand<\/li>\n\n\n\n<li>NCT05882045 | A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease | ClinicalTrials.gov\uff08\u80a5\u6e80\u75c7\u3068\u5fc3\u8840\u7ba1\u75be\u60a3\u306e\u53c2\u52a0\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30ec\u30bf\u30c8\u30eb\u30c1\u30c9\u306e\u81e8\u5e8a\u8a66\u9a13\u306e\u8a73\u7d30\u60c5\u5831\u3067\u3059\u3002\uff09 https:\/\/clinicaltrials.gov\/study\/NCT05882045<\/li>\n\n\n\n<li>Top 10 most anticipated drug launches of 2026 &#8211; Fierce Pharma\uff082026\u5e74\u306b\u6700\u3082\u671f\u5f85\u3055\u308c\u308b\u533b\u85ac\u54c1\u767a\u58f2\u30c8\u30c3\u30d710\u304c\u7d39\u4ecb\u3055\u308c\u3066\u3044\u307e\u3059\u3002\uff09 https:\/\/www.fiercepharma.com\/marketing\/top-10-most-anticipated-drug-launches-2026<\/li>\n\n\n\n<li>2026 Key Drug Launches | Evaluate Report\uff082026\u5e74\u306e\u4e3b\u8981\u306a\u533b\u85ac\u54c1\u767a\u58f2\u306b\u95a2\u3059\u308b\u30ec\u30dd\u30fc\u30c8\u3067\u3059\u3002\uff09 https:\/\/www.evaluate.com\/thought-leadership\/2026-key-drug-launches\/<\/li>\n\n\n\n<li>2026 Pipelines to watch &#8211; PharmaLive\uff082026\u5e74\u306b\u6ce8\u76ee\u3059\u3079\u304d\u533b\u85ac\u54c1\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306b\u95a2\u3059\u308b\u60c5\u5831\u3067\u3059\u3002\uff09 https:\/\/www.pharmalive.com\/2026-pipelines-to-watch\/<\/li>\n\n\n\n<li>FDA Accepts BLA for Datopotamab Deruxtecan in Pretreated Advanced Nonsquamous NSCLC | OncLive\uff08\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\u304c\u3001\u524d\u6cbb\u7642\u6b74\u306e\u3042\u308b\u9032\u884c\u975e\u6241\u5e73\u4e0a\u76ae\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\u306b\u5bfe\u3059\u308b\u30c0\u30c8\u30dd\u30bf\u30de\u30d6 \u30c7\u30eb\u30af\u30b9\u30c6\u30ab\u30f3\uff08Dato-DXd\uff09\u306e\u751f\u7269\u5b66\u7684\u88fd\u5264\u627f\u8a8d\u7533\u8acb\u3092\u53d7\u7406\u3057\u305f\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/www.onclive.com\/view\/fda-accepts-bla-for-datopotamab-deruxtecan-in-pretreated-advanced-nonsquamous-nsclc<\/li>\n\n\n\n<li>Press Release &#8211; Datopotamab Deruxtecan New Drug Application Submitted in Japan for Patients with Previously Treated Advanced HR Positive, HER2 Negative Breast Cancer &#8211; Daiichi Sankyo\uff08\u7b2c\u4e00\u4e09\u5171\u304c\u3001\u524d\u6cbb\u7642\u6b74\u306e\u3042\u308b\u9032\u884c\u30db\u30eb\u30e2\u30f3\u53d7\u5bb9\u4f53\u967d\u6027\u3001HER2\u9670\u6027\u4e73\u304c\u3093\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30c0\u30c8\u30dd\u30bf\u30de\u30d6 \u30c7\u30eb\u30af\u30b9\u30c6\u30ab\u30f3\u306e\u65b0\u85ac\u627f\u8a8d\u7533\u8acb\u3092\u65e5\u672c\u3067\u884c\u3063\u305f\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/www.daiichisankyo.com\/files\/news\/pressrelease\/pdf\/202403\/20240314_E.pdf<\/li>\n\n\n\n<li>Report on the Deliberation Results December 11, 2024 Pharmaceutical Evaluation Division, Pharmaceutical Safety Bureau Ministry o\uff08\u539a\u751f\u52b4\u50cd\u7701\u533b\u85ac\u5b89\u5168\u5c40\u533b\u85ac\u54c1\u8a55\u4fa1\u8ab2\u306b\u3088\u308b2024\u5e7412\u670811\u65e5\u306e\u5be9\u8b70\u7d50\u679c\u5831\u544a\u66f8\u3067\u3059\u3002\uff09 https:\/\/www.pmda.go.jp\/files\/000277284.pdf<\/li>\n\n\n\n<li>FDA approves datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer &#8211; Food and Drug Administration\uff08\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\u304c\u3001\u5207\u9664\u4e0d\u80fd\u307e\u305f\u306f\u8ee2\u79fb\u6027\u306e\u30db\u30eb\u30e2\u30f3\u53d7\u5bb9\u4f53\u967d\u6027\u3001HER2\u9670\u6027\u4e73\u304c\u3093\u306b\u5bfe\u3059\u308b\u30c0\u30c8\u30dd\u30bf\u30de\u30d6 \u30c7\u30eb\u30af\u30b9\u30c6\u30ab\u30f3\u3092\u627f\u8a8d\u3057\u305f\u60c5\u5831\u3067\u3059\u3002\uff09 https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-datopotamab-deruxtecan-dlnk-unresectable-or-metastatic-hr-positive-her2-negative-breast<\/li>\n\n\n\n<li>FDA Approves Daiichi Sankyo datopotamab \/ Datroway for Advanced Breast Cancer &#8211; Key Trial Data &#8211; YouTube\uff08\u7b2c\u4e00\u4e09\u5171\u306e\u30c0\u30c8\u30dd\u30bf\u30de\u30d6\u304c\u9032\u884c\u4e73\u304c\u3093\u3067\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\u306b\u627f\u8a8d\u3055\u308c\u305f\u4e3b\u8981\u306a\u6cbb\u9a13\u30c7\u30fc\u30bf\u306b\u95a2\u3059\u308bYouTube\u52d5\u753b\u3067\u3059\u3002\uff09 https:\/\/www.youtube.com\/watch?v=XA6MswA-LfM<\/li>\n\n\n\n<li>DATROWAY\u00ae (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy &#8211; AstraZeneca\uff08\u30a2\u30b9\u30c8\u30e9\u30bc\u30cd\u30ab\u304c\u3001\u514d\u75ab\u7642\u6cd5\u306b\u9069\u683c\u3067\u306a\u3044\u8ee2\u79fb\u6027\u30c8\u30ea\u30d7\u30eb\u30cd\u30ac\u30c6\u30a3\u30d6\u4e73\u304c\u3093\u60a3\u8005\u306e\u4e00\u6b21\u6cbb\u7642\u3068\u3057\u3066\u3001\u30c0\u30c8\u30dd\u30bf\u30de\u30d6 \u30c7\u30eb\u30af\u30b9\u30c6\u30ab\u30f3\u304c\u7c73\u56fd\u3067\u512a\u5148\u5be9\u67fb\u6307\u5b9a\u3092\u53d7\u3051\u305f\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/www.astrazeneca-us.com\/media\/press-releases\/2026\/DATROWAY-datopotamab-deruxtecan-dlnk-granted-Priority-Review-in-the-US-as-1st-line-treatment-for-patients-with-metastatic-triple-negative-breast-cancer-who-are-not-candidates-for-immunotherapy.html<\/li>\n\n\n\n<li>FDA Approves Datopotamab Deruxtecan for EGFR-Mutated NSCLC &#8211; AJMC\uff08\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\u304c\u3001EGFR\u5909\u7570\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\u306b\u5bfe\u3059\u308b\u30c0\u30c8\u30dd\u30bf\u30de\u30d6 \u30c7\u30eb\u30af\u30b9\u30c6\u30ab\u30f3\u3092\u627f\u8a8d\u3057\u305f\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/www.ajmc.com\/view\/fda-approves-datopotamab-deruxtecan-for-egfr-mutated-nsclc<\/li>\n\n\n\n<li>Datopotamab deruxtecan granted Priority Review in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer &#8211; AstraZeneca\uff08\u30a2\u30b9\u30c8\u30e9\u30bc\u30cd\u30ab\u304c\u3001\u524d\u6cbb\u7642\u6b74\u306e\u3042\u308b\u9032\u884cEGFR\u5909\u7570\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30c0\u30c8\u30dd\u30bf\u30de\u30d6 \u30c7\u30eb\u30af\u30b9\u30c6\u30ab\u30f3\u304c\u7c73\u56fd\u3067\u512a\u5148\u5be9\u67fb\u6307\u5b9a\u3092\u53d7\u3051\u305f\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2025\/datopotamab-deruxtecan-granted-priority-review-in-the-us-for-patients-with-previously-treated-advanced-egfr-mutated-non-small-cell-lung-cancer.html<\/li>\n\n\n\n<li>Phase 3 Clinical Study of AK112 for NSCLC Patients &#8211; Cancer Trial Results\uff08\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fAK112\u306e\u7b2cIII\u76f8\u81e8\u5e8a\u8a66\u9a13\u306e\u8a73\u7d30\u60c5\u5831\u3067\u3059\u3002\uff09 https:\/\/clin.larvol.com\/trial-detail\/NCT05184712<\/li>\n\n\n\n<li>Ivonescimab combined with chemotherapy in patients with EGFR-mutant non-squamous non-small cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor treatment (HARMONi-A): A randomized, double-blind, multi-center, phase 3 trial. &#8211; ASCO\uff08EGFR\u30c1\u30ed\u30b7\u30f3\u30ad\u30ca\u30fc\u30bc\u963b\u5bb3\u5264\u6cbb\u7642\u5f8c\u306b\u9032\u884c\u3057\u305fEGFR\u5909\u7570\u975e\u6241\u5e73\u4e0a\u76ae\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\u60a3\u8005\u306b\u304a\u3051\u308b\u30a4\u30dc\u30cd\u30b9\u30b7\u30de\u30d6\u3068\u5316\u5b66\u7642\u6cd5\u306e\u4f75\u7528\u306b\u95a2\u3059\u308b\u7b2cIII\u76f8\u8a66\u9a13\u306e\u6982\u8981\u3067\u3059\u3002\uff09 https:\/\/www.asco.org\/abstracts-presentations\/232409<\/li>\n\n\n\n<li>Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China &#8211; PubMed\uff08PD-L1\u967d\u6027\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30a4\u30dc\u30cd\u30b9\u30b7\u30de\u30d6\u3068\u30da\u30e0\u30d6\u30ed\u30ea\u30ba\u30de\u30d6\u306e\u6bd4\u8f03\u306b\u95a2\u3059\u308b\u7b2cIII\u76f8\u8a66\u9a13\uff08HARMONi-2\uff09\u306e\u7d50\u679c\u3067\u3059\u3002\uff09 https:\/\/pubmed.ncbi.nlm.nih.gov\/40057343\/<\/li>\n\n\n\n<li>Akeso Announces The Publication of Its Phase III Clinical Trial Results for Ivonescimab in Head-to-Head Comparison with Pembrolizumab in The Lancet &#8211; PR Newswire\uff08Akeso\u793e\u304c\u3001\u30a4\u30dc\u30cd\u30b9\u30b7\u30de\u30d6\u3068\u30da\u30e0\u30d6\u30ed\u30ea\u30ba\u30de\u30d6\u306e\u76f4\u63a5\u6bd4\u8f03\u306b\u95a2\u3059\u308b\u7b2cIII\u76f8\u81e8\u5e8a\u8a66\u9a13\u7d50\u679c\u3092Lancet\u8a8c\u306b\u63b2\u8f09\u3057\u305f\u3068\u767a\u8868\u3057\u305f\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/www.prnewswire.com\/news-releases\/akeso-announces-the-publication-of-its-phase-iii-clinical-trial-results-for-ivonescimab-in-head-to-head-comparison-with-pembrolizumab-in-the-lancet-302395382.html<\/li>\n\n\n\n<li>Ivonescimab Outperforms Pembrolizumab as Frontline Therapy in PD-L1+ Advanced NSCLC | OncLive\uff08PD-L1\u967d\u6027\u9032\u884c\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\u306e\u4e00\u6b21\u6cbb\u7642\u306b\u304a\u3044\u3066\u3001\u30a4\u30dc\u30cd\u30b9\u30b7\u30de\u30d6\u304c\u30da\u30e0\u30d6\u30ed\u30ea\u30ba\u30de\u30d6\u3092\u4e0a\u56de\u308b\u52b9\u679c\u3092\u793a\u3057\u305f\u3068\u3044\u3046\u8a18\u4e8b\u3067\u3059\u3002\uff09 https:\/\/www.onclive.com\/view\/ivonescimab-outperforms-pembrolizumab-as-frontline-therapy-in-pd-l1-advanced-nsclc<\/li>\n\n\n\n<li>\u30b5\u30df\u30c3\u30c8\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u304c\u5927\u5e45\u9ad8 \u80ba\u304c\u3093\u6cbb\u7642\u85ac\u300c\u30a4\u30dc\u30cd\u30b9\u30b7\u30de\u30d6\u300d\u306e\u81e8\u5e8a\u8a66\u9a13\u3067\u597d\u7d50\u679c\uff1d\u7c73\u56fd\u682a\u500b\u5225\uff08\u30b5\u30df\u30c3\u30c8\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u304c\u3001\u80ba\u304c\u3093\u6cbb\u7642\u85ac\u30a4\u30dc\u30cd\u30b9\u30b7\u30de\u30d6\u306e\u81e8\u5e8a\u8a66\u9a13\u3067\u826f\u597d\u306a\u7d50\u679c\u3092\u793a\u3057\u3001\u682a\u4fa1\u304c\u5927\u5e45\u306b\u4e0a\u6607\u3057\u305f\u3068\u3044\u3046\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/kabutan.jp\/news\/marketnews\/?b=n202409090951<\/li>\n\n\n\n<li>NCT03897881 | An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942) | ClinicalTrials.gov\uff08\u9ad8\u30ea\u30b9\u30af\u30e1\u30e9\u30ce\u30fc\u30de\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u500b\u5225\u5316\u304c\u3093\u30ef\u30af\u30c1\u30f3mRNA-4157\u3068\u30da\u30e0\u30d6\u30ed\u30ea\u30ba\u30de\u30d6\u306e\u4f75\u7528\u306b\u3088\u308b\u88dc\u52a9\u7642\u6cd5\u306b\u95a2\u3059\u308b\u6709\u52b9\u6027\u8a66\u9a13\u306e\u8a73\u7d30\u60c5\u5831\u3067\u3059\u3002\uff09 https:\/\/clinicaltrials.gov\/study\/NCT03897881<\/li>\n\n\n\n<li>Individualized neoantigen therapy mRNA-4157 (V940) plus pembrolizumab in resected melanoma: 3-year update from the mRNA-4157-P201 (KEYNOTE-942) trial. &#8211; ASCO\uff08\u5207\u9664\u3055\u308c\u305f\u30e1\u30e9\u30ce\u30fc\u30de\u60a3\u8005\u306b\u304a\u3051\u308b\u500b\u5225\u5316\u30cd\u30aa\u30a2\u30f3\u30c1\u30b2\u30f3\u7642\u6cd5mRNA-4157\u3068\u30da\u30e0\u30d6\u30ed\u30ea\u30ba\u30de\u30d6\u306e\u4f75\u7528\u306b\u95a2\u3059\u308b3\u5e74\u9593\u306e\u6700\u65b0\u60c5\u5831\u3067\u3059\u3002\uff09 https:\/\/www.asco.org\/abstracts-presentations\/233031<\/li>\n\n\n\n<li>Moderna &amp; Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA\u00ae (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III\/IV Melanoma Following Complete Resection\uff08Moderna\u3068Merck\u304c\u3001\u9ad8\u30ea\u30b9\u30af\u30b9\u30c6\u30fc\u30b8III\/IV\u30e1\u30e9\u30ce\u30fc\u30de\u60a3\u8005\u306b\u304a\u3051\u308b\u30a4\u30f3\u30c8\u30a3\u30b9\u30e1\u30e9\u30de\u30fb\u30aa\u30fc\u30c8\u30b8\u30fc\u30f3\u3068KEYTRUDA\u00ae\u4f75\u7528\u306b\u3088\u308b5\u5e74\u9593\u306e\u30c7\u30fc\u30bf\u3067\u3001\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3067\u3042\u308b\u7121\u518d\u767a\u751f\u5b58\u671f\u9593\u306e\u6301\u7d9a\u7684\u306a\u6539\u5584\u3092\u793a\u3057\u305f\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002\uff09 https:\/\/www.merck.com\/news\/moderna-merck-announce-5-year-data-for-intismeran-autogene-in-combination-with-keytruda-pembrolizumab-demonstrated-sustained-improvement-in-the-primary-endpoint-of-recurrence-free-survival-i\/<\/li>\n\n\n\n<li>KEYNOTE-942 Trial: 5-Year Follow-Up Benefit of Personalized mRNA Vaccine Plus Pembrolizumab in High-Risk Melanoma &#8211; OncoDaily\uff08\u9ad8\u30ea\u30b9\u30af\u30e1\u30e9\u30ce\u30fc\u30de\u60a3\u8005\u306b\u304a\u3051\u308b\u500b\u5225\u5316mRNA\u30ef\u30af\u30c1\u30f3\u3068\u30da\u30e0\u30d6\u30ed\u30ea\u30ba\u30de\u30d6\u4f75\u7528\u7642\u6cd5\u306e5\u5e74\u9593\u8ffd\u8de1\u8abf\u67fb\u306e\u5229\u76ca\u306b\u95a2\u3059\u308bKEYNOTE-942\u8a66\u9a13\u306e\u7d50\u679c\u3067\u3059\u3002\uff09 https:\/\/oncodaily.com\/oncolibrary\/keynote-942<\/li>\n\n\n\n<li>An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942) &#8211; Cancer Trial Results\uff08\u9ad8\u30ea\u30b9\u30af\u30e1\u30e9\u30ce\u30fc\u30de\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u500b\u5225\u5316\u304c\u3093\u30ef\u30af\u30c1\u30f3mRNA-4157\u3068\u30da\u30e0\u30d6\u30ed\u30ea\u30ba\u30de\u30d6\u306e\u4f75\u7528\u306b\u3088\u308b\u88dc\u52a9\u7642\u6cd5\u306b\u95a2\u3059\u308b\u6709\u52b9\u6027\u8a66\u9a13\u306e\u8a73\u7d30\u60c5\u5831\u3067\u3059\u3002\uff09 https:\/\/clin.larvol.com\/trial-detail\/NCT03897881<\/li>\n\n\n\n<li>Expanding the Alzheimer&#8217;s Treatment Landscape: A 2026 Forecast &#8211; BrightFocus Foundation\uff082026\u5e74\u307e\u3067\u306e\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u6cbb\u7642\u306e\u5c55\u671b\u3092\u4e88\u6e2c\u3057\u305f\u30ec\u30dd\u30fc\u30c8\u3067\u3059\u3002\uff09 https:\/\/www.brightfocus.org\/resource\/expanding-the-alzheimers-treatment-landscape-a-2026-forecast\/<\/li>\n\n\n\n<li>4 Next-Gen Candidates That Could Form the Future of Alzheimer&#8217;s Treatment &#8211; BioSpace\uff08\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u6cbb\u7642\u306e\u672a\u6765\u3092\u5f62\u4f5c\u308b\u53ef\u80fd\u6027\u306e\u3042\u308b\u6b21\u4e16\u4ee3\u5019\u88dc\u85ac4\u3064\u306b\u3064\u3044\u3066\u7d39\u4ecb\u3057\u3066\u3044\u307e\u3059\u3002\uff09 https:\/\/www.biospace.com\/drug-development\/4-next-gen-candidates-that-could-form-the-future-of-alzheimers-treatment<\/li>\n\n\n\n<li>Trontinemab | ALZFORUM\uff08\u30c8\u30ed\u30f3\u30c1\u30cd\u30de\u30d6\u306b\u95a2\u3059\u308b\u8a73\u7d30\u60c5\u5831\u304c\u63b2\u8f09\u3055\u308c\u3066\u3044\u307e\u3059\u3002\uff09 https:\/\/www.alzforum.org\/therapeutics\/trontinemab<\/li>\n\n\n\n<li>Potential Alzheimer&#8217;s treatment, trontinemab, hits the news \u2013 how does it work and is it available? &#8211; Alzheimer&#8217;s Research UK\uff08\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u306e\u6f5c\u5728\u7684\u306a\u6cbb\u7642\u85ac\u3067\u3042\u308b\u30c8\u30ed\u30f3\u30c1\u30cd\u30de\u30d6\u304c\u30cb\u30e5\u30fc\u30b9\u306b\u306a\u3063\u305f\u7d4c\u7def\u3001\u305d\u306e\u4f5c\u7528\u6a5f\u5e8f\u3001\u304a\u3088\u3073\u5165\u624b\u53ef\u80fd\u6027\u306b\u3064\u3044\u3066\u89e3\u8aac\u3057\u3066\u3044\u307e\u3059\u3002\uff09 https:\/\/www.alzheimersresearchuk.org\/news\/potential-alzheimers-treatment-trontinemab-hits-the-news-how-does-it-work-and-is-it-available\/<\/li>\n\n\n\n<li>Study Details | NCT07170150 | A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer&#8217;s Disease | ClinicalTrials.gov\uff08\u65e9\u671f\u75c7\u5019\u6027\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u306e\u53c2\u52a0\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30c8\u30ed\u30f3\u30c1\u30cd\u30de\u30d6\u306e\u81e8\u5e8a\u8a66\u9a13\u306e\u8a73\u7d30\u60c5\u5831\u3067\u3059\u3002\uff09 https:\/\/clinicaltrials.gov\/study\/NCT07170150<\/li>\n\n\n\n<li>BIIB080 \u2013 MAPTRX ASO &#8211; Alzheimer&#8217;s Drug Discovery Foundation\uff08\u30bf\u30a6\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u6a19\u7684\u3068\u3059\u308b\u30a2\u30f3\u30c1\u30bb\u30f3\u30b9\u30aa\u30ea\u30b4\u30cc\u30af\u30ec\u30aa\u30c1\u30c9BIIB080\u306b\u95a2\u3059\u308b\u60c5\u5831\u3067\u3059\u3002\uff09 https:\/\/www.alzdiscovery.org\/uploads\/cognitive_vitality_media\/BIIB080_(drug_under_development).pdf<\/li>\n\n\n\n<li>Biogen&#8217;s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer&#8217;s Disease &#8211; Biogen Investors\uff08Biogen\u793e\u306e\u958b\u767a\u4e2d\u306e\u30bf\u30a6\u6a19\u7684\u7642\u6cd5BIIB080\u304c\u3001\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u6cbb\u7642\u85ac\u3068\u3057\u3066\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\u306e\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3092\u53d7\u3051\u305f\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/investors.biogen.com\/news-releases\/news-release-details\/biogens-investigational-tau-targeting-therapy-biib080-receives<\/li>\n\n\n\n<li>Biogen&#8217;s Much Anticipated Tau Readout in Alzheimer&#8217;s Will Spur More Questions &#8211; BioSpace\uff08Biogen\u793e\u306e\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u306b\u304a\u3051\u308b\u30bf\u30a6\u95a2\u9023\u306e\u30c7\u30fc\u30bf\u767a\u8868\u304c\u3001\u3055\u3089\u306a\u308b\u7591\u554f\u3092\u547c\u3076\u3060\u308d\u3046\u3068\u3044\u3046\u8a18\u4e8b\u3067\u3059\u3002\uff09 https:\/\/www.biospace.com\/drug-development\/biogens-much-anticipated-tau-readout-in-alzheimers-will-spur-more-questions<\/li>\n\n\n\n<li>Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial &#8211; PubMed\uff08\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fBIIB080\u306e\u8907\u6570\u56de\u5897\u91cf\u6295\u4e0e\u8a66\u9a13\u306b\u304a\u3051\u308b\u30bf\u30a6\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u306e\u63a2\u7d22\u7684\u7d50\u679c\u3067\u3059\u3002\uff09 https:\/\/pubmed.ncbi.nlm.nih.gov\/37902726\/<\/li>\n\n\n\n<li>Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1\/2a Study of ARO-MAPT for the Treatment of Alzheimer&#8217;s Disease and Other Tauopathies &#8211; Arrowhead Pharmaceuticals Investors\uff08Arrowhead Pharmaceuticals\u304c\u3001\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u304a\u3088\u3073\u305d\u306e\u4ed6\u306e\u30bf\u30a6\u30aa\u30d1\u30c1\u30fc\u6cbb\u7642\u85acARO-MAPT\u306e\u7b2cI\/IIa\u76f8\u8a66\u9a13\u958b\u59cb\u306e\u305f\u3081\u306e\u898f\u5236\u5f53\u5c40\u306e\u627f\u8a8d\u3092\u7533\u8acb\u3057\u305f\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/ir.arrowheadpharma.com\/news-releases\/news-release-details\/arrowhead-pharmaceuticals-requests-regulatory-clearance-0<\/li>\n\n\n\n<li>Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates &#8211; Intellia Therapeutics Investors\uff08Intellia Therapeutics\u304c\u30012025\u5e74\u7b2c4\u56db\u534a\u671f\u304a\u3088\u3073\u901a\u5e74\u306e\u8ca1\u52d9\u7d50\u679c\u3068\u4e8b\u696d\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3092\u767a\u8868\u3057\u305f\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/ir.intelliatx.com\/news-releases\/news-release-details\/intellia-therapeutics-announces-fourth-quarter-and-full-year-8<\/li>\n\n\n\n<li>Intellia (NASDAQ: NTLA) eyes 2027 HAE launch as key ATTR trial faces FDA hold &#8211; StockTitan\uff08Intellia Therapeutics\u304c2027\u5e74\u306e\u907a\u4f1d\u6027\u8840\u7ba1\u6027\u6d6e\u816b\u6cbb\u7642\u85ac\u306e\u767a\u58f2\u3092\u76ee\u6307\u3059\u4e2d\u3001ATTR\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u8a66\u9a13\u304c\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\u306e\u4fdd\u7559\u306b\u76f4\u9762\u3057\u305f\u3068\u3044\u3046\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/www.stocktitan.net\/sec-filings\/NTLA\/10-k-intellia-therapeutics-inc-files-annual-report-63ba521c555b.html<\/li>\n\n\n\n<li>Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026 &#8211; Intellia Therapeutics Investors\uff08Intellia Therapeutics\u304c\u3001\u907a\u4f1d\u6027\u8840\u7ba1\u6027\u6d6e\u816b\u6cbb\u7642\u85ac\u30ed\u30f3\u30dc\u30b0\u30e9\u30f3\u30fb\u30b8\u30af\u30eb\u30e1\u30e9\u30f3\u306e\u9577\u671f\u81e8\u5e8a\u30c7\u30fc\u30bf\u3092AAAI 2026\u3067\u767a\u8868\u3057\u305f\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/ir.intelliatx.com\/news-releases\/news-release-details\/intellia-therapeutics-presents-longer-term-clinical-data<\/li>\n\n\n\n<li>Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM &#8211; Intellia Therapeutics Investors\uff08Intellia Therapeutics\u304c\u3001ATTR\u5fc3\u7b4b\u75c7\u306b\u5bfe\u3059\u308b\u7b2cIII\u76f8MAGNITUDE\u81e8\u5e8a\u8a66\u9a13\u306e\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\u306b\u3088\u308b\u81e8\u5e8a\u4fdd\u7559\u89e3\u9664\u3092\u767a\u8868\u3057\u305f\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/ir.intelliatx.com\/news-releases\/news-release-details\/intellia-therapeutics-announces-fda-lift-clinical-hold-0<\/li>\n\n\n\n<li>Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN &#8211; Intellia Therapeutics Investors\uff08Intellia Therapeutics\u304c\u3001ATTRv-PN\u306b\u5bfe\u3059\u308b\u7b2cIII\u76f8MAGNITUDE-2\u81e8\u5e8a\u8a66\u9a13\u306e\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\u306b\u3088\u308b\u81e8\u5e8a\u4fdd\u7559\u89e3\u9664\u3092\u767a\u8868\u3057\u305f\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/ir.intelliatx.com\/news-releases\/news-release-details\/intellia-therapeutics-announces-fda-lift-clinical-hold-magnitude<\/li>\n\n\n\n<li>Rare Disease Drug Trends 2026 &#8211; Breakthrough Therapies &#8211; Clarivate\uff082026\u5e74\u306e\u5e0c\u5c11\u75be\u60a3\u6cbb\u7642\u85ac\u306e\u30c8\u30ec\u30f3\u30c9\u3068\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u306b\u95a2\u3059\u308b\u60c5\u5831\u3067\u3059\u3002\uff09 https:\/\/clarivate.com\/drugs-to-watch\/key-trends\/rare-chronic-disease\/<\/li>\n\n\n\n<li>\u9769\u65b0\u7684\u306a\u533b\u85ac\u54c1\u5e02\u5834\u898f\u6a21\u3001\u682a\u5f0f\u30fb\u5206\u6790\u30012025-2032 &#8211; Coherent Market Insights\uff082025\u5e74\u304b\u30892032\u5e74\u307e\u3067\u306e\u9769\u65b0\u7684\u306a\u533b\u85ac\u54c1\u5e02\u5834\u898f\u6a21\u3001\u682a\u5f0f\u3001\u5206\u6790\u306b\u95a2\u3059\u308b\u60c5\u5831\u3067\u3059\u3002\uff09 https:\/\/www.coherentmarketinsights.com\/ja\/%E9%9D%A9%E6%96%B0%E7%9A%84%E3%81%AA%E5%8C%BB%E7%99%82%E5%B8%82%E5%A0%B4<\/li>\n\n\n\n<li>AI Applications in the Drug Development Pipeline | IntuitionLabs\uff08\u533b\u85ac\u54c1\u958b\u767a\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306b\u304a\u3051\u308bAI\u306e\u5fdc\u7528\u306b\u95a2\u3059\u308b\u8a18\u4e8b\u3067\u3059\u3002\uff09 https:\/\/intuitionlabs.ai\/articles\/ai-drug-development-pipeline<\/li>\n\n\n\n<li>Accelerating Drug Development with AI in the U.S. Pharmaceutical Industry | IntuitionLabs\uff08\u7c73\u56fd\u88fd\u85ac\u696d\u754c\u306b\u304a\u3051\u308bAI\u306b\u3088\u308b\u533b\u85ac\u54c1\u958b\u767a\u306e\u52a0\u901f\u306b\u95a2\u3059\u308b\u8a18\u4e8b\u3067\u3059\u3002\uff09 https:\/\/intuitionlabs.ai\/articles\/accelerating-drug-development-ai-pharma<\/li>\n\n\n\n<li>How AI is Transforming Drug Discovery &#8211; Pharmaceutical Law Group\uff08AI\u304c\u533b\u85ac\u54c1\u767a\u898b\u3092\u3069\u306e\u3088\u3046\u306b\u5909\u9769\u3057\u3066\u3044\u308b\u304b\u306b\u3064\u3044\u3066\u306e\u8a18\u4e8b\u3067\u3059\u3002\uff09 https:\/\/www.pharmalawgrp.com\/blog\/22\/recursion-exscientia-merger-ais-impact-on-modern-drug-discovery\/<\/li>\n\n\n\n<li>Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update &#8211; FirstWord Pharma\uff08Recursion\u793e\u304c2025\u5e74\u7b2c4\u56db\u534a\u671f\u304a\u3088\u3073\u901a\u5e74\u306e\u8ca1\u52d9\u7d50\u679c\u3068\u4e8b\u696d\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3092\u767a\u8868\u3057\u305f\u30cb\u30e5\u30fc\u30b9\u3067\u3059\u3002\uff09 https:\/\/firstwordpharma.com\/story\/7115368<\/li>\n\n\n\n<li>\u533b\u7642\u6a5f\u95a2\u306e\u516c\u958b\u60c5\u5831\uff08\u7d4c\u53e3GLP-1\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac\u30aa\u30eb\u30d5\u30a9\u30eb\u30b0\u30ea\u30d7\u30ed\u30f3\u306b\u95a2\u3059\u308b\u8ad6\u6587\u7d39\u4ecb\u3067\u3059\u3002\uff09 https:\/\/mb-clinic.jp\/topics\/2026\/02\/11\/orforglipron\/<\/li>\n\n\n\n<li>\u30a4\u30fc\u30e9\u30a4\u30ea\u30ea\u30fc\u306e\u30ec\u30bf\u30c8\u30eb\u30c1\u30c9\u300c\u4f53\u91cd28.7%\u6e1b\u5c11\u300d\u306e\u885d\u6483\u2015\u80a5\u6e80\u75c7\u6cbb\u7642\u85ac\u3001\u6700\u65b0\u306e\u4e3b\u306a\u958b\u767a\u52d5\u5411\uff08\u30a4\u30fc\u30e9\u30a4\u30ea\u30ea\u30fc\u793e\u306e\u30ec\u30bf\u30c8\u30eb\u30c1\u30c9\u304c\u4f53\u91cd28.7%\u6e1b\u5c11\u3092\u9054\u6210\u3057\u305f\u3068\u3044\u3046\u885d\u6483\u7684\u306a\u30cb\u30e5\u30fc\u30b9\u3068\u3001\u80a5\u6e80\u75c7\u6cbb\u7642\u85ac\u306e\u6700\u65b0\u958b\u767a\u52d5\u5411\u306b\u3064\u3044\u3066\u89e3\u8aac\u3057\u3066\u3044\u307e\u3059\u3002\uff09 https:\/\/answers.and-pro.jp\/pharmanews\/31494\/<\/li>\n\n\n\n<li>\u539a\u751f\u52b4\u50cd\u7701 \u6cbb\u9a13\u306b\u3064\u3044\u3066\uff08\u539a\u751f\u52b4\u50cd\u7701\u306b\u3088\u308b\u6cbb\u9a13\u306e\u6982\u8981\u306b\u95a2\u3059\u308b\u8cc7\u6599\u3067\u3059\u3002\uff09 https:\/\/www.mhlw.go.jp\/shingi\/2005\/03\/dl\/s0329-13d.pdf<\/li>\n<\/ul>\n\n\n\n<h2 style=\"color:#43A047;font-size:1.4em;margin-bottom:16px;border-bottom:3px solid #43A047;padding-bottom:8px\">\u75be\u60a3\u3092\u304a\u6301\u3061\u306e\u65b9\u5411\u3051\u306e\u52df\u96c6\u4e2d\u6848\u4ef6<\/h2>\n\n\n\n<table style=\"width:100%;border-collapse:collapse;background:#fff;border-radius:8px;overflow:hidden;box-shadow:0 1px 3px rgba(0,0,0,0.08)\"><thead><tr style=\"background:#43A047;border-bottom:2px solid #43A047\"><th style=\"padding:14px;text-align:left;color:#fff;font-weight:600;font-size:0.9em\">\u6848\u4ef6\u540d<\/th><th style=\"padding:14px;text-align:left;color:#fff;font-weight:600;font-size:0.9em\">\u5730\u57df<\/th><th style=\"padding:14px;text-align:left;color:#fff;font-weight:600;font-size:0.9em\">\u5bfe\u8c61<\/th><th style=\"padding:14px;text-align:left;color:#fff;font-weight:600;font-size:0.9em\">\u8ca0\u62c5\u8efd\u6e1b\u8cbb<\/th><th style=\"padding:14px;text-align:left;color:#fff;font-weight:600;font-size:0.9em\">\u65e5\u7a0b<\/th><th style=\"padding:14px;text-align:center;color:#fff;font-weight:600;font-size:0.9em\">\u72b6\u6cc1<\/th><\/tr><\/thead><tbody>\n<tr style=\"background:#fff;border-bottom:1px solid #e8e8e8\"><td style=\"padding:12px 14px\"><a href=\"https:\/\/chiken-net.site\/products\/detail\/1002843\" target=\"_blank\" rel=\"noopener\" style=\"color:#2e7d32;text-decoration:none;font-weight:500\">\u7247\u982d\u75db\u3067\u304a\u60a9\u307f\u306e\u5c0f\u5150\uff086\uff5e17\u6b73\uff09\u306e\u65b9<\/a><\/td><td style=\"padding:12px 14px;white-space:nowrap\">\u95a2\u6771<\/td><td style=\"padding:12px 14px;white-space:nowrap\">\u7537\u6027<\/td><td style=\"padding:12px 14px;white-space:nowrap;font-weight:500\">\u5fdc\u52df\u5f8c\u958b\u793a<\/td><td style=\"padding:12px 14px;white-space:nowrap;font-size:0.9em\">\u6700\u957719\u9031\u9593<\/td><td style=\"padding:12px 14px;text-align:center\"><span style=\"color:#fff;background:#43A047;padding:2px 10px;border-radius:4px;font-size:0.85em;font-weight:bold\">\u52df\u96c6\u4e2d<\/span><\/td><\/tr>\n<tr style=\"background:#fff;border-bottom:1px solid #e8e8e8\"><td style=\"padding:12px 14px\"><a href=\"https:\/\/chiken-net.site\/products\/detail\/1000541\" target=\"_blank\" rel=\"noopener\" style=\"color:#2e7d32;text-decoration:none;font-weight:500\">\u95a2\u897f\/\u4eac\u90fd\u5e9c\/\u7d99\u7d9a\u52df\u96c6\u4e2d<\/a><\/td><td style=\"padding:12px 14px;white-space:nowrap\">\u95a2\u897f<\/td><td style=\"padding:12px 14px;white-space:nowrap\">\u7537\u6027<\/td><td style=\"padding:12px 14px;white-space:nowrap;font-weight:500\">\u5fdc\u52df\u5f8c\u958b\u793a<\/td><td style=\"padding:12px 14px;white-space:nowrap;font-size:0.9em\">\u7d045\u30f6\u6708\u7a0b\u5ea6<\/td><td style=\"padding:12px 14px;text-align:center\"><span style=\"color:#fff;background:#43A047;padding:2px 10px;border-radius:4px;font-size:0.85em;font-weight:bold\">\u52df\u96c6\u4e2d<\/span><\/td><\/tr>\n<tr style=\"background:#fff;border-bottom:1px solid #e8e8e8\"><td style=\"padding:12px 14px\"><a href=\"https:\/\/chiken-net.site\/products\/detail\/1000243\" target=\"_blank\" rel=\"noopener\" style=\"color:#2e7d32;text-decoration:none;font-weight:500\">\u3046\u3064\u3068\u7591\u308f\u308c\u308b\u75c7\u72b6\u3067\u304a\u60a9\u307f\u306e\u65b9<\/a><\/td><td style=\"padding:12px 14px;white-space:nowrap\">\u798f\u5ca1<\/td><td style=\"padding:12px 14px;white-space:nowrap\">\u7537\u6027<\/td><td style=\"padding:12px 14px;white-space:nowrap;font-weight:500\">\u5fdc\u52df\u5f8c\u958b\u793a<\/td><td style=\"padding:12px 14px;white-space:nowrap;font-size:0.9em\"><\/td><td style=\"padding:12px 14px;text-align:center\"><span style=\"color:#fff;background:#43A047;padding:2px 10px;border-radius:4px;font-size:0.85em;font-weight:bold\">\u52df\u96c6\u4e2d<\/span><\/td><\/tr>\n<tr style=\"background:#fff;border-bottom:1px solid #e8e8e8\"><td style=\"padding:12px 14px\"><a href=\"https:\/\/chiken-net.site\/products\/detail\/1002972\" target=\"_blank\" rel=\"noopener\" style=\"color:#2e7d32;text-decoration:none;font-weight:500\">\u7247\u982d\u75db\u3067\u304a\u60a9\u307f\u306e\u5c0f\u5150\uff086\uff5e17\u6b73\uff09\u306e\u65b9<\/a><\/td><td style=\"padding:12px 14px;white-space:nowrap\">\u95a2\u6771<\/td><td style=\"padding:12px 14px;white-space:nowrap\">\u7537\u6027<\/td><td style=\"padding:12px 14px;white-space:nowrap;font-weight:500\">\u5fdc\u52df\u5f8c\u958b\u793a<\/td><td style=\"padding:12px 14px;white-space:nowrap;font-size:0.9em\">\u6700\u957776\u9031\u9593<\/td><td style=\"padding:12px 14px;text-align:center\"><span style=\"color:#fff;background:#43A047;padding:2px 10px;border-radius:4px;font-size:0.85em;font-weight:bold\">\u52df\u96c6\u4e2d<\/span><\/td><\/tr>\n<\/tbody><\/table>\n\n\n\n<p style=\"font-size:0.85em;color:#888;margin-top:8px\">\u203b\u6848\u4ef6\u60c5\u5831\u306f2026-05-03\u6642\u70b9\u306e\u3082\u306e\u3067\u3059\u3002\u6700\u65b0\u306e\u52df\u96c6\u72b6\u6cc1\u306f\u5404\u6848\u4ef6\u30da\u30fc\u30b8\u3067\u3054\u78ba\u8a8d\u304f\u3060\u3055\u3044\u3002<\/p>\n\n\n\n<div style=\"background:#ffffff;border:2px solid #43A047;border-radius:10px;padding:28px 24px;margin:24px 0;text-align:center\"><h3 style=\"color:#43A047;margin:0 0 12px 0;font-size:1.2em\">\u75be\u60a3\u3092\u304a\u6301\u3061\u306e\u65b9\u5411\u3051\u306e\u65b0\u7740\u6848\u4ef6\u60c5\u5831<\/h3><p style=\"color:#444;margin:0 0 20px 0;line-height:1.7\">\u4ed6\u306b\u3082<span style=\"font-size:1.4em;font-weight:bold\">4<\/span>\u4ef6\u4ee5\u4e0a\u306e\u6848\u4ef6\u304c\u52df\u96c6\u4e2d\u3067\u3059\u3002\u7121\u6599\u4f1a\u54e1\u767b\u9332\u3059\u308b\u3068\u3001\u65b0\u7740\u6848\u4ef6\u3092\u30e1\u30fc\u30eb\u3067\u304a\u77e5\u3089\u305b\u3057\u307e\u3059\u3002<\/p><a href=\"https:\/\/chiken-net.site\/entry\" target=\"_blank\" rel=\"noopener\" style=\"display:inline-block;background:#43A047;color:#fff;padding:14px 48px;border-radius:6px;text-decoration:none;font-weight:bold;font-size:1.05em\">\u7121\u6599\u4f1a\u54e1\u767b\u9332\u306f\u3053\u3061\u3089<\/a><p style=\"color:#999;font-size:0.8em;margin:14px 0 0 0\">\u203b\u767b\u9332\u306f\u7d041\u5206\u3067\u5b8c\u4e86\u3057\u307e\u3059\u3002\u6cbb\u9a13\u3078\u306e\u53c2\u52a0\u7fa9\u52d9\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p><\/div>\n\n\n\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"2026\u5e74\u306b\u6ce8\u76ee\u3055\u308c\u308b\u65b0\u85ac\u5019\u88dc\u306e\u4e3b\u306a\u5206\u91ce\u306f\u4f55\u3067\u3059\u304b\uff1f\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"\u80a5\u6e80\u75c7\u30fb\u7cd6\u5c3f\u75c5\u6cbb\u7642\u3001\u304c\u3093\u6cbb\u7642\u3001\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u306a\u3069\u306e\u795e\u7d4c\u5909\u6027\u75be\u60a3\u3001\u907a\u4f1d\u5b50\u7de8\u96c6\u3001AI\u5275\u85ac\u3068\u3044\u3063\u305f\u5206\u91ce\u3067\u753b\u671f\u7684\u306a\u65b0\u85ac\u5019\u88dc\u304c\u6ce8\u76ee\u3055\u308c\u3066\u3044\u307e\u3059\u3002\"}},{\"@type\":\"Question\",\"name\":\"\u6cbb\u9a13\u306f\u672a\u6765\u306e\u533b\u7642\u306b\u3069\u306e\u3088\u3046\u306b\u8ca2\u732e\u3057\u307e\u3059\u304b\uff1f\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"\u6cbb\u9a13\u306f\u3001\u65b0\u85ac\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u3092\u79d1\u5b66\u7684\u306b\u691c\u8a3c\u3057\u3001\u6cbb\u7642\u6cd5\u306e\u300c\u5b8c\u6cbb\u300d\u3084\u300c\u60a3\u8005\u4e2d\u5fc3\u306e\u5229\u4fbf\u6027\u300d\u300c\u500b\u5225\u5316\u533b\u7642\u306e\u6df1\u5316\u300d\u3068\u3044\u3063\u305f\u672a\u6765\u306e\u533b\u7642\u306e\u5b9f\u73fe\u306b\u4e0d\u53ef\u6b20\u306a\u30d7\u30ed\u30bb\u30b9\u3067\u3059\u3002\"}},{\"@type\":\"Question\",\"name\":\"AI\u306f\u65b0\u85ac\u958b\u767a\u306b\u3069\u306e\u3088\u3046\u306b\u6d3b\u7528\u3055\u308c\u3066\u3044\u307e\u3059\u304b\uff1f\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"AI\u306f\u3001\u30bf\u30fc\u30b2\u30c3\u30c8\u306e\u7279\u5b9a\u304b\u3089\u5019\u88dc\u7269\u8cea\u306e\u6700\u9069\u5316\u307e\u3067\u3001\u533b\u85ac\u54c1\u958b\u767a\u30b5\u30a4\u30af\u30eb\u3092\u5287\u7684\u306b\u77ed\u7e2e\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u6cbb\u9a13\u306e\u8a2d\u8a08\u6700\u9069\u5316\u306b\u3082\u8ca2\u732e\u3057\u3001\u6210\u529f\u7387\u3092\u9ad8\u3081\u3066\u3044\u307e\u3059\u3002\"}}]}<\/script>\n","protected":false},"excerpt":{"rendered":"<p>2026\u5e74\u5b9f\u7528\u5316\u671f\u5f85\u306e\u65b0\u85ac\u5019\u88dc\u3092\u89e3\u8aac\u3002\u80a5\u6e80\u75c7\u30fb\u7cd6\u5c3f\u75c5\u6cbb\u7642\u306e\u6700\u524d\u7dda\u3001\u6cbb\u9a13\u306e\u4ed5\u7d44\u307f\u3001\u672a\u6765\u306e\u533b\u7642\u3092\u5909\u3048\u308b\u53ef\u80fd\u6027\u3092\u6df1\u6398\u308a\u3002\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u77e5\u308a\u3001\u672a\u6765\u306e\u5065\u5eb7\u3092\u8003\u3048\u307e\u305b\u3093\u304b\uff1f\u3002\u5c02\u9580\u5bb6\u306e\u89e3\u8aac\u3092\u898b\u308b<\/p>\n","protected":false},"author":5,"featured_media":3055,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_focuskw":"\u65b0\u85ac\u5019\u88dc 2026 \u6cbb\u9a13","_yoast_wpseo_title":"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027","_yoast_wpseo_metadesc":"2026\u5e74\u5b9f\u7528\u5316\u671f\u5f85\u306e\u65b0\u85ac\u5019\u88dc\u3092AI\u7de8\u96c6\u9577\u304c\u89e3\u8aac\u3002\u80a5\u6e80\u75c7\u30fb\u7cd6\u5c3f\u75c5\u6cbb\u7642\u306e\u6700\u524d\u7dda\u3001\u6cbb\u9a13\u306e\u4ed5\u7d44\u307f\u3001\u672a\u6765\u306e\u533b\u7642\u3092\u5909\u3048\u308b\u53ef\u80fd\u6027\u3092\u6df1\u6398\u308a\u3002\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u77e5\u308a\u3001\u672a\u6765\u306e\u5065\u5eb7\u3092\u8003\u3048\u307e\u305b\u3093\u304b\uff1f\u3002\u5c02\u9580\u5bb6\u306e\u89e3\u8aac\u3092\u898b\u308b","footnotes":""},"categories":[15],"tags":[],"class_list":["post-3058","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-disease"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027<\/title>\n<meta name=\"description\" content=\"2026\u5e74\u5b9f\u7528\u5316\u671f\u5f85\u306e\u65b0\u85ac\u5019\u88dc\u3092AI\u7de8\u96c6\u9577\u304c\u89e3\u8aac\u3002\u80a5\u6e80\u75c7\u30fb\u7cd6\u5c3f\u75c5\u6cbb\u7642\u306e\u6700\u524d\u7dda\u3001\u6cbb\u9a13\u306e\u4ed5\u7d44\u307f\u3001\u672a\u6765\u306e\u533b\u7642\u3092\u5909\u3048\u308b\u53ef\u80fd\u6027\u3092\u6df1\u6398\u308a\u3002\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u77e5\u308a\u3001\u672a\u6765\u306e\u5065\u5eb7\u3092\u8003\u3048\u307e\u305b\u3093\u304b\uff1f\u3002\u5c02\u9580\u5bb6\u306e\u89e3\u8aac\u3092\u898b\u308b\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027\" \/>\n<meta property=\"og:description\" content=\"2026\u5e74\u5b9f\u7528\u5316\u671f\u5f85\u306e\u65b0\u85ac\u5019\u88dc\u3092AI\u7de8\u96c6\u9577\u304c\u89e3\u8aac\u3002\u80a5\u6e80\u75c7\u30fb\u7cd6\u5c3f\u75c5\u6cbb\u7642\u306e\u6700\u524d\u7dda\u3001\u6cbb\u9a13\u306e\u4ed5\u7d44\u307f\u3001\u672a\u6765\u306e\u533b\u7642\u3092\u5909\u3048\u308b\u53ef\u80fd\u6027\u3092\u6df1\u6398\u308a\u3002\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u77e5\u308a\u3001\u672a\u6765\u306e\u5065\u5eb7\u3092\u8003\u3048\u307e\u305b\u3093\u304b\uff1f\u3002\u5c02\u9580\u5bb6\u306e\u89e3\u8aac\u3092\u898b\u308b\" \/>\n<meta property=\"og:url\" content=\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"\u6cbb\u9a13\u30cd\u30c3\u30c8\u30b3\u30e9\u30e0\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-10T03:17:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-02T21:01:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112388260-0-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1396\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u5b89\u85e4\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u5b89\u85e4\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"52\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/\"},\"author\":{\"name\":\"\u5b89\u85e4\",\"@id\":\"https:\/\/chiken-net.site\/column\/#\/schema\/person\/a7735708f3fd05d94b020d7924163f52\"},\"headline\":\"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027\",\"datePublished\":\"2026-03-10T03:17:55+00:00\",\"dateModified\":\"2026-05-02T21:01:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/\"},\"wordCount\":1331,\"publisher\":{\"@id\":\"https:\/\/chiken-net.site\/column\/#organization\"},\"image\":{\"@id\":\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112388260-0-scaled.jpg\",\"articleSection\":[\"\u75be\u60a3\u5225\u6cbb\u9a13\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/\",\"url\":\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/\",\"name\":\"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027\",\"isPartOf\":{\"@id\":\"https:\/\/chiken-net.site\/column\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112388260-0-scaled.jpg\",\"datePublished\":\"2026-03-10T03:17:55+00:00\",\"dateModified\":\"2026-05-02T21:01:12+00:00\",\"description\":\"2026\u5e74\u5b9f\u7528\u5316\u671f\u5f85\u306e\u65b0\u85ac\u5019\u88dc\u3092AI\u7de8\u96c6\u9577\u304c\u89e3\u8aac\u3002\u80a5\u6e80\u75c7\u30fb\u7cd6\u5c3f\u75c5\u6cbb\u7642\u306e\u6700\u524d\u7dda\u3001\u6cbb\u9a13\u306e\u4ed5\u7d44\u307f\u3001\u672a\u6765\u306e\u533b\u7642\u3092\u5909\u3048\u308b\u53ef\u80fd\u6027\u3092\u6df1\u6398\u308a\u3002\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u77e5\u308a\u3001\u672a\u6765\u306e\u5065\u5eb7\u3092\u8003\u3048\u307e\u305b\u3093\u304b\uff1f\u3002\u5c02\u9580\u5bb6\u306e\u89e3\u8aac\u3092\u898b\u308b\",\"breadcrumb\":{\"@id\":\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#primaryimage\",\"url\":\"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112388260-0-scaled.jpg\",\"contentUrl\":\"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112388260-0-scaled.jpg\",\"width\":2560,\"height\":1396,\"caption\":\"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027 - \u30a4\u30e1\u30fc\u30b8\u30a4\u30e9\u30b9\u30c8\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u30db\u30fc\u30e0\",\"item\":\"https:\/\/chiken-net.site\/column\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/chiken-net.site\/column\/#website\",\"url\":\"https:\/\/chiken-net.site\/column\/\",\"name\":\"\u6cbb\u9a13\u30cd\u30c3\u30c8\u30b3\u30e9\u30e0\",\"description\":\"\u30e2\u30cb\u30bf\u30fc\u591a\u6570\u52df\u96c6\uff01\u6cbb\u9a13\u30a2\u30eb\u30d0\u30a4\u30c8\u63a2\u3059\u306a\u3089\u6cbb\u9a13\u30cd\u30c3\u30c8\",\"publisher\":{\"@id\":\"https:\/\/chiken-net.site\/column\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/chiken-net.site\/column\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/chiken-net.site\/column\/#organization\",\"name\":\"\u682a\u5f0f\u4f1a\u793eLDM\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u30ba\",\"url\":\"https:\/\/chiken-net.site\/column\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/chiken-net.site\/column\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2025\/12\/header-logo.png\",\"contentUrl\":\"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2025\/12\/header-logo.png\",\"width\":402,\"height\":110,\"caption\":\"\u682a\u5f0f\u4f1a\u793eLDM\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u30ba\"},\"image\":{\"@id\":\"https:\/\/chiken-net.site\/column\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/chiken-net.site\/column\/#\/schema\/person\/a7735708f3fd05d94b020d7924163f52\",\"name\":\"\u5b89\u85e4\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/chiken-net.site\/column\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3850dc374a010f1fc87ca1e7da6a0b1563460962d331f41fa9bf78559990a29b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3850dc374a010f1fc87ca1e7da6a0b1563460962d331f41fa9bf78559990a29b?s=96&d=mm&r=g\",\"caption\":\"\u5b89\u85e4\"},\"description\":\"\u30fb\u8a8d\u5b9a\u30db\u30b9\u30d4\u30bf\u30eb\u30a8\u30f3\u30b8\u30cb\u30a2 \u4f1a\u54e1\u756a\u53f764A051 \u30fb\u533b\u7642\u7d4c\u55b6\u58eb3 \u7d1a \u8a8d\u5b9a\u756a\u53f7 \u7b2c31410020010036 \u53f7 \u7d4c\u6b74 \u30fbPHASE1\u65bd\u8a2d\u30fbSMO\u306b\u3066\u7ba1\u7406\u8077\uff08\u30b7\u30cb\u30a2\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\uff09 \u30fb\u75c5\u9662\u3067\u306f\u4e8b\u52d9\u90e8\u7d71\u62ec\u8ab2\u9577\uff08\u533b\u4e8b\u30fb\u8a2a\u554f\u8a3a\u7642\u30b5\u30dd\u30fc\u30c8\u30fb\u533b\u7642\u8a2d\u5099\/\u533b\u7642\u6a5f\u5668\u7ba1\u7406\uff09\",\"url\":\"https:\/\/chiken-net.site\/column\/author\/make_api\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027","description":"2026\u5e74\u5b9f\u7528\u5316\u671f\u5f85\u306e\u65b0\u85ac\u5019\u88dc\u3092AI\u7de8\u96c6\u9577\u304c\u89e3\u8aac\u3002\u80a5\u6e80\u75c7\u30fb\u7cd6\u5c3f\u75c5\u6cbb\u7642\u306e\u6700\u524d\u7dda\u3001\u6cbb\u9a13\u306e\u4ed5\u7d44\u307f\u3001\u672a\u6765\u306e\u533b\u7642\u3092\u5909\u3048\u308b\u53ef\u80fd\u6027\u3092\u6df1\u6398\u308a\u3002\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u77e5\u308a\u3001\u672a\u6765\u306e\u5065\u5eb7\u3092\u8003\u3048\u307e\u305b\u3093\u304b\uff1f\u3002\u5c02\u9580\u5bb6\u306e\u89e3\u8aac\u3092\u898b\u308b","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/","og_locale":"ja_JP","og_type":"article","og_title":"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027","og_description":"2026\u5e74\u5b9f\u7528\u5316\u671f\u5f85\u306e\u65b0\u85ac\u5019\u88dc\u3092AI\u7de8\u96c6\u9577\u304c\u89e3\u8aac\u3002\u80a5\u6e80\u75c7\u30fb\u7cd6\u5c3f\u75c5\u6cbb\u7642\u306e\u6700\u524d\u7dda\u3001\u6cbb\u9a13\u306e\u4ed5\u7d44\u307f\u3001\u672a\u6765\u306e\u533b\u7642\u3092\u5909\u3048\u308b\u53ef\u80fd\u6027\u3092\u6df1\u6398\u308a\u3002\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u77e5\u308a\u3001\u672a\u6765\u306e\u5065\u5eb7\u3092\u8003\u3048\u307e\u305b\u3093\u304b\uff1f\u3002\u5c02\u9580\u5bb6\u306e\u89e3\u8aac\u3092\u898b\u308b","og_url":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/","og_site_name":"\u6cbb\u9a13\u30cd\u30c3\u30c8\u30b3\u30e9\u30e0","article_published_time":"2026-03-10T03:17:55+00:00","article_modified_time":"2026-05-02T21:01:12+00:00","og_image":[{"width":2560,"height":1396,"url":"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112388260-0-scaled.jpg","type":"image\/jpeg"}],"author":"\u5b89\u85e4","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"\u5b89\u85e4","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"52\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#article","isPartOf":{"@id":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/"},"author":{"name":"\u5b89\u85e4","@id":"https:\/\/chiken-net.site\/column\/#\/schema\/person\/a7735708f3fd05d94b020d7924163f52"},"headline":"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027","datePublished":"2026-03-10T03:17:55+00:00","dateModified":"2026-05-02T21:01:12+00:00","mainEntityOfPage":{"@id":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/"},"wordCount":1331,"publisher":{"@id":"https:\/\/chiken-net.site\/column\/#organization"},"image":{"@id":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112388260-0-scaled.jpg","articleSection":["\u75be\u60a3\u5225\u6cbb\u9a13"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/","url":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/","name":"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027","isPartOf":{"@id":"https:\/\/chiken-net.site\/column\/#website"},"primaryImageOfPage":{"@id":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#primaryimage"},"image":{"@id":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112388260-0-scaled.jpg","datePublished":"2026-03-10T03:17:55+00:00","dateModified":"2026-05-02T21:01:12+00:00","description":"2026\u5e74\u5b9f\u7528\u5316\u671f\u5f85\u306e\u65b0\u85ac\u5019\u88dc\u3092AI\u7de8\u96c6\u9577\u304c\u89e3\u8aac\u3002\u80a5\u6e80\u75c7\u30fb\u7cd6\u5c3f\u75c5\u6cbb\u7642\u306e\u6700\u524d\u7dda\u3001\u6cbb\u9a13\u306e\u4ed5\u7d44\u307f\u3001\u672a\u6765\u306e\u533b\u7642\u3092\u5909\u3048\u308b\u53ef\u80fd\u6027\u3092\u6df1\u6398\u308a\u3002\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u77e5\u308a\u3001\u672a\u6765\u306e\u5065\u5eb7\u3092\u8003\u3048\u307e\u305b\u3093\u304b\uff1f\u3002\u5c02\u9580\u5bb6\u306e\u89e3\u8aac\u3092\u898b\u308b","breadcrumb":{"@id":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#primaryimage","url":"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112388260-0-scaled.jpg","contentUrl":"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2026\/03\/article-1773112388260-0-scaled.jpg","width":2560,"height":1396,"caption":"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027 - \u30a4\u30e1\u30fc\u30b8\u30a4\u30e9\u30b9\u30c8"},{"@type":"BreadcrumbList","@id":"https:\/\/chiken-net.site\/column\/future-medicine-new-drugs-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u30db\u30fc\u30e0","item":"https:\/\/chiken-net.site\/column\/"},{"@type":"ListItem","position":2,"name":"\u672a\u6765\u306e\u533b\u7642\u3092\u62d3\u304f\u65b0\u85ac\u5019\u88dc2026\uff1a\u6cbb\u9a13\u304b\u3089\u751f\u307e\u308c\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u305d\u306e\u53ef\u80fd\u6027"}]},{"@type":"WebSite","@id":"https:\/\/chiken-net.site\/column\/#website","url":"https:\/\/chiken-net.site\/column\/","name":"\u6cbb\u9a13\u30cd\u30c3\u30c8\u30b3\u30e9\u30e0","description":"\u30e2\u30cb\u30bf\u30fc\u591a\u6570\u52df\u96c6\uff01\u6cbb\u9a13\u30a2\u30eb\u30d0\u30a4\u30c8\u63a2\u3059\u306a\u3089\u6cbb\u9a13\u30cd\u30c3\u30c8","publisher":{"@id":"https:\/\/chiken-net.site\/column\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/chiken-net.site\/column\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/chiken-net.site\/column\/#organization","name":"\u682a\u5f0f\u4f1a\u793eLDM\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u30ba","url":"https:\/\/chiken-net.site\/column\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/chiken-net.site\/column\/#\/schema\/logo\/image\/","url":"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2025\/12\/header-logo.png","contentUrl":"https:\/\/chiken-net.site\/column\/wp-content\/uploads\/2025\/12\/header-logo.png","width":402,"height":110,"caption":"\u682a\u5f0f\u4f1a\u793eLDM\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u30ba"},"image":{"@id":"https:\/\/chiken-net.site\/column\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/chiken-net.site\/column\/#\/schema\/person\/a7735708f3fd05d94b020d7924163f52","name":"\u5b89\u85e4","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/chiken-net.site\/column\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3850dc374a010f1fc87ca1e7da6a0b1563460962d331f41fa9bf78559990a29b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3850dc374a010f1fc87ca1e7da6a0b1563460962d331f41fa9bf78559990a29b?s=96&d=mm&r=g","caption":"\u5b89\u85e4"},"description":"\u30fb\u8a8d\u5b9a\u30db\u30b9\u30d4\u30bf\u30eb\u30a8\u30f3\u30b8\u30cb\u30a2 \u4f1a\u54e1\u756a\u53f764A051 \u30fb\u533b\u7642\u7d4c\u55b6\u58eb3 \u7d1a \u8a8d\u5b9a\u756a\u53f7 \u7b2c31410020010036 \u53f7 \u7d4c\u6b74 \u30fbPHASE1\u65bd\u8a2d\u30fbSMO\u306b\u3066\u7ba1\u7406\u8077\uff08\u30b7\u30cb\u30a2\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\uff09 \u30fb\u75c5\u9662\u3067\u306f\u4e8b\u52d9\u90e8\u7d71\u62ec\u8ab2\u9577\uff08\u533b\u4e8b\u30fb\u8a2a\u554f\u8a3a\u7642\u30b5\u30dd\u30fc\u30c8\u30fb\u533b\u7642\u8a2d\u5099\/\u533b\u7642\u6a5f\u5668\u7ba1\u7406\uff09","url":"https:\/\/chiken-net.site\/column\/author\/make_api\/"}]}},"_links":{"self":[{"href":"https:\/\/chiken-net.site\/column\/wp-json\/wp\/v2\/posts\/3058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chiken-net.site\/column\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chiken-net.site\/column\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chiken-net.site\/column\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/chiken-net.site\/column\/wp-json\/wp\/v2\/comments?post=3058"}],"version-history":[{"count":10,"href":"https:\/\/chiken-net.site\/column\/wp-json\/wp\/v2\/posts\/3058\/revisions"}],"predecessor-version":[{"id":9747,"href":"https:\/\/chiken-net.site\/column\/wp-json\/wp\/v2\/posts\/3058\/revisions\/9747"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chiken-net.site\/column\/wp-json\/wp\/v2\/media\/3055"}],"wp:attachment":[{"href":"https:\/\/chiken-net.site\/column\/wp-json\/wp\/v2\/media?parent=3058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chiken-net.site\/column\/wp-json\/wp\/v2\/categories?post=3058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chiken-net.site\/column\/wp-json\/wp\/v2\/tags?post=3058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}